Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2010 Annual Meeting | Poster Session 04

Wednesday 04/14/10
03:00 PM - 07:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Aging and Dementia, Anterior Horn, Autonomic Disorders, Behavioral Neurology, Headache, Infections/AIDS/Prion Disease, MS and Related Diseases, Neuroepidemiology/Health Services and Outcomes Research, Neurogenetics and Gene Therapy, Neurologic Â鶹´«Ã½Ó³»­, Neurotoxicology, Peripheral Nerve
No CME available
Event Timeline
03:00 PM - 04:30 PM Break
03:00 PM - 07:30 PM Abstract 001 - Reversible Hypohidrosis with Topiramate Therapy for Chronic Migraine
03:00 PM - 07:30 PM Abstract 002 - Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): Could It Be an Autoimmune Disease?
03:00 PM - 07:30 PM Abstract 003 - Application of the Kano Methodology for Evaluating Migraine Treatment Expectations among Neurologists in Spain. The MIGREXX Study
03:00 PM - 07:30 PM Abstract 004 - High Migraine Frequency May Be Associated with Increased Interictal Platelet Activation in Episodic Migraine
03:00 PM - 07:30 PM Abstract 005 - Response of SUNCT (Short-Lasting Unilateral Neuralgiform Headaches with Conjunctival Injection and Tearing), SUNA (Short-Lasting Unilateral Neuralgiform Headaches with Autonomic Symptoms) and Primary Stabbing Headaches to Occipital Nerve Stimulation (ONS)
03:00 PM - 07:30 PM Abstract 006 - Lifetime Anxiety Symptoms in Migrainous Vertigo
03:00 PM - 07:30 PM Abstract 007 - Evaluation of Efficacy and Safety of MAP0004 in Reversing Central Sensitization and Treating Migraine in Established Allodynic Patients
03:00 PM - 07:30 PM Abstract 008 - The Timing of Gastric Stasis in an Acute Migraine and Its Impact on Treatment
03:00 PM - 07:30 PM Abstract 009 - Occipital Neuralgia as an Isolated Symptom of Bone Metastasis Caused by Hepatocellular Carcinoma
03:00 PM - 07:30 PM Abstract 010 - Posttraumatic and Postsurgical Nummular Headache
03:00 PM - 07:30 PM Abstract 011 - Clinical Phenotypes and Morphological Changes of the Circle of Willis in Migraineurs
03:00 PM - 07:30 PM Abstract 012 - Syncopal Migraine: Migraine as a Cause of Syncope
03:00 PM - 07:30 PM Abstract 013 - Putative Clinical, Mechanical and Local Paracrine Mechanisms of Pituitary Adenoma-Attributed Headache
03:00 PM - 07:30 PM Abstract 014 - Spinal Subdural Collection in the Setting of a Spontaneous Cerebrospinal Fluid Leak
03:00 PM - 07:30 PM Abstract 015 - The Headache Under-Response to Treatment (HURT) Index: An Instrument Developed by the Lifting the Burden Campaign To Improve Management of Headache, Especially in Primary Care
03:00 PM - 07:30 PM Abstract 016 - Scleral Buckle as a Unique Cause of Facial Pain
03:00 PM - 07:30 PM Abstract 017 - Determinants of Migraine-Related Disability
03:00 PM - 07:30 PM Abstract 018 - Magnetic Resonance Perfusion Imaging in Hemiplegic Migraine
03:00 PM - 07:30 PM Abstract 019 - Migrainous Vertigo Presenting in the Perimenopause
03:00 PM - 07:30 PM Abstract 020 - Spatial Vision, Intellectual Loss and Neuroimaging Variables as Predictors of Constructional Apraxia in Patients with Cerebrovascular Disease
03:00 PM - 07:30 PM Abstract 021 - Spatially Adherent Graphemic Perseveration
03:00 PM - 07:30 PM Abstract 022 - Atypical Presentation of Cerebellar Mutism in an Adult
03:00 PM - 07:30 PM Abstract 023 - Effect of Â鶹´«Ã½Ó³»­ on Severity of Language Dysfunction after Stroke
03:00 PM - 07:30 PM Abstract 024 - Narrative Discourse in Parkinson Disease
03:00 PM - 07:30 PM Abstract 025 - You Don't Say: A New Variant of PPA?
03:00 PM - 07:30 PM Abstract 026 - Quantifier Comprehension in Corticobasal Syndrome and Frontotemporal Degeneration
03:00 PM - 07:30 PM Abstract 027 - Extrapyramidal Signs in Primary Progressive Aphasia
03:00 PM - 07:30 PM Abstract 028 - Impaired Decision-Making Strategies for Pronoun Resolution in Behavioral-Variant Frontotemporal Dementia (bvFTD)
03:00 PM - 07:30 PM Abstract 029 - Language Circuits Investigated with Semantic Decision/Tone Decision fMRI Task and Independent Component Analysis (ICA)
03:00 PM - 07:30 PM Abstract 030 - Double Dissociation of Semantic and Episodic Memory Impairment in Temporal Variant Frontotemporal Dementia and Alzheimer's Disease
03:00 PM - 07:30 PM Abstract 031 - False Recognition of Unfamiliar Faces in Frontotemporal Dementia
03:00 PM - 07:30 PM Abstract 032 - Loss of Future Oriented Behavior in a Patient with Behavioral Variant Frontotemporal Dementia
03:00 PM - 07:30 PM Abstract 033 - MRI Features Mimicking Limbic Encephalitis and CJD in Hashimoto's Encephalopathy without Paraneoplastic Antibodies
03:00 PM - 07:30 PM Abstract 034 - Profiles of Performance in Verbal Serial List Learning in Alzheimer's Disease and Semantic Dementia
03:00 PM - 07:30 PM Abstract 035 - Patterns of Memory Deficit Modify the Rate of Conversion to Dementia in a Large Sample of Patients with Mild Cognitive Impairment
03:00 PM - 07:30 PM Abstract 036 - Graphabulation, a New Form of Confabulation
03:00 PM - 07:30 PM Abstract 037 - Vitamin D, Fall Frequency, and Cognitive Function in Free-Living Elders
03:00 PM - 07:30 PM Abstract 038 - Prospective Evaluation of 32 Patients with Symptoms of Transient Global Amnesia (TGA) in a Community Hospital of Argentina
03:00 PM - 07:30 PM Abstract 039 - Hyposmia, Central Cholinergic Integrity and Cognitive Impairment in Parkinson Disease without Dementia
03:00 PM - 07:30 PM Abstract 040 - Dissociation between Two Routes to Action in Gesture Imitation
03:00 PM - 07:30 PM Abstract 041 - Gait Disorders, an Interesting Marker of Frontotemporal Dementia
03:00 PM - 07:30 PM Abstract 042 - Validation of a Simple Bedside Antisaccade Task in Neurodegenerative Dementia
03:00 PM - 07:30 PM Abstract 043 - Reckless Driving Associated with Dopamine Agonist Use: A Case Series
03:00 PM - 07:30 PM Abstract 044 - Right Inferior Frontal Gyrus Is Necessary for Interference Suppression, but Not Error Correction, in the Eriksen Flanker Task
03:00 PM - 07:30 PM Abstract 045 - Executive Functions and Cognition in Amyotrophic Lateral Sclerosis
03:00 PM - 07:30 PM Abstract 046 - Insight of Involuntary Movements in Early Huntington's Disease: A Simple Explanation
03:00 PM - 07:30 PM Abstract 047 - Relationship between Cognition and Spatiotemporal Gait Parameters in Parkinson Disease without Dementia
03:00 PM - 07:30 PM Abstract 048 - Quantification of Increased Mirror Overflow in ADHD: Laterality and Gender Effects
03:00 PM - 07:30 PM Abstract 049 - Excessive Hoarding in Parkinson's Disease
03:00 PM - 07:30 PM Abstract 050 - Neuropsychological Profile of Adult Patients with Duchenne Muscular Dystrophy
03:00 PM - 07:30 PM Abstract 051 - Trends in Outcomes and Hospitalization Costs among Patients with Warding's Hoffman Disease in the United States
03:00 PM - 07:30 PM Abstract 052 - The Role of Ulnar Compound Muscle Action Potential (U-CMAP) as a Surrogate Outcome Measure in Ambulatory Adults with Spinal Muscular Atrophy (AA-SMA)
03:00 PM - 07:30 PM Abstract 053 - Beta-Lactam Antibiotics Offer Neuroprotection in a Spinal Muscular Atrophy Mouse Model by Multiple Mechanisms
03:00 PM - 07:30 PM Abstract 054 - Salbutamol Increases SMN mRNA in Spinal Muscular Atrophy Patients (SMA): Relevance for Clinical Trial Design
03:00 PM - 07:30 PM Abstract 055 - Further Progress in Defining UBE-1 Mutations and Downstream Effects Underlying X-Linked Lethal Infantile SMA (XL-SMA)
03:00 PM - 07:30 PM Abstract 056 - Hand Held Dynamometry and Fixed Maximal Voluntary Isometric Contraction Strength Testing in Ambulatory Adults with Spinal Muscular Atrophy
03:00 PM - 07:30 PM Abstract 057 - Biomarker Study for Spinal Muscular Atrophy: Study Design and Preliminary Results
03:00 PM - 07:30 PM Abstract 058 - Videofluorography in Spinal and Bulbar Muscular Atrophy (SBMA)
03:00 PM - 07:30 PM Abstract 059 - Reliability of the Six Minute Walk Test in Ambulatory Patients with Spinal Muscular Atrophy
03:00 PM - 07:30 PM Abstract 060 - Fatigue Related Spatiotemporal Gait Changes during the Six Minute Walk Test in Spinal Muscular Atrophy (SMA)
03:00 PM - 07:30 PM Abstract 061 - A Novel BSCL2/Seipin Variant Associated with Atypical Silver Syndrome Mimicking ALS
03:00 PM - 07:30 PM Abstract 062 - Studies of Sequence Changes of the Dynactin p150 Gene In Vitro
03:00 PM - 07:30 PM Abstract 063 - FUS Mutations in a Large Series of Sporadic and Familial ALS
03:00 PM - 07:30 PM Abstract 064 - Fronto-Temporal Dementia in 3 ALS Families with TARDBP Missense Mutation
03:00 PM - 07:30 PM Abstract 065 - The Mutational Spectrum of Adult Onset Dominant-Inherited Familial Amyotrophic Lateral Sclerosis in Chinese Population on Taiwan
03:00 PM - 07:30 PM Abstract 066 - Initial Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS) - A Global Web-Based Registry
03:00 PM - 07:30 PM Abstract 067 - Skin Denervation in Amyloid Neuropathy with a Hot-Spot Mutation of Transthyretin (Ala97Ser) in Taiwan
03:00 PM - 07:30 PM Abstract 068 - Outcome Measures for Transthyretin Type Familial Amyloid Polyneuropathy
03:00 PM - 07:30 PM Abstract 069 - Post-Liver Transplant ATTR Val30Met Patients: CNS Clinical Phenotype
03:00 PM - 07:30 PM Abstract 070 - Transthyretin Familial Amyloid Polyneuropathy: Does a Mitochondrial Polymorphism Entirely Explain the Parent-of-Origin Difference in Penetrance?
03:00 PM - 07:30 PM Abstract 071 - Patterns of Amyloid Deposition in Individual Patients with Mild Cognitive Impairment: An 11C-PIB PET Study
03:00 PM - 07:30 PM Abstract 072 - Cortical Thickness Change in Alzheimer's Disease over 6 Months: Data from ADNI
03:00 PM - 07:30 PM Abstract 073 - Can We Use Pons as a Reference Region for the Analysis of [11C]PIB PET?
03:00 PM - 07:30 PM Abstract 074 - Florbetaben [beta]-Amyloid Brain PET - Correlation with Cognition Parameters in Alzheimer Disease
03:00 PM - 07:30 PM Abstract 075 - Voxel-Based Longitudinal Changes of Gray Matter Density in Incipient Alzheimer's Disease
03:00 PM - 07:30 PM Abstract 076 - In Cognitively Healthy and Mildly Impaired Individuals Florbetapir F 18 PET Measures of Amyloid Deposition Correlate with the Degree of Functional Impairment Assessed Six Months Later
03:00 PM - 07:30 PM Abstract 077 - FDG-PET Pattern in Patients with White Matter Changes with and without Dementia: Differentiation from Alzheimer Disease
03:00 PM - 07:30 PM Abstract 078 - Hippocampal Activation during Episodic Memory Processing in Healthy Adult Apolipoprotein E [epsilon]4 Carriers Is Significantly Influenced by Age
03:00 PM - 07:30 PM Abstract 079 - The Changes of Cortical Gray Matter in Alzheimer's Disease According to Clinical Dementia Rating: Voxel Based Morphometric Study
03:00 PM - 07:30 PM Abstract 080 - Progression of Prodromal AD Associated with Amyloid Deposition Using PIB PET Imaging
03:00 PM - 07:30 PM Abstract 082 - Capgras Syndrome and the Cognitive Neuroscience of Attachment
03:00 PM - 07:30 PM Abstract 083 - Diagnostic Serendipity in Evaluating Normal-Pressure Hydrocephalus
03:00 PM - 07:30 PM Abstract 084 - Verbal Memory Decline in Alzheimer's Disease Is Associated with an Impairment of Frontal Executive Control
03:00 PM - 07:30 PM Abstract 085 - Evidence That Cognitive Activities during Adulthood Modify the Reserve-Building Effects of Â鶹´«Ã½Ó³»­
03:00 PM - 07:30 PM Abstract 086 - The Cognitive Reserve Reflected in Sex Differences Is Not Altered by APOE Genotype
03:00 PM - 07:30 PM Abstract 087 - Micronutrients and Neuropsychologic Function in Patients with Mild Cognitive Impairment and Alzheimer's Disease
03:00 PM - 07:30 PM Abstract 088 - Development of a Caregiver Burden Assessment in Alzheimer's Disease
03:00 PM - 07:30 PM Abstract 089 - Assessing Differences in Co-Morbidities, Utilization, and Expenditures for Alzheimer's Medicare Beneficiaries Compared to the Non-Alzheimer's Medicare Population
03:00 PM - 07:30 PM Abstract 090 - Clinically Confirmed Normal Pressure Hydrocephalus Usually Has Alzheimer's Disease Pathology at Autopsy
03:00 PM - 07:30 PM Abstract 091 - Intranasal Insulin Modulates Hippocampal Activation According to APOE-[epsilon]4 Genotype in Early Alzheimer's Disease
03:00 PM - 07:30 PM Abstract 092 - Age-Related Changes in Processing Syntactically Ambiguous Sentences: Evidence from fMRI
03:00 PM - 07:30 PM Abstract 093 - Diagnostic Value of Presenting Symptoms and Physical Signs in Spinal Dural Arteriovenous Fistula
03:00 PM - 07:30 PM Abstract 094 - The Northern Manhattan Study Global Vascular Risk Score Is Associated with Cognitive Performance
03:00 PM - 07:30 PM Abstract 095 - Augmented Treatment Efficacy [mdash] A Repeated Measures Analysis of NINDS rt-PA Study
03:00 PM - 07:30 PM Abstract 096 - Increased Expression of the Endocannabinoid Receptor 1 in Acute Human Stroke
03:00 PM - 07:30 PM Abstract 097 - Ischemic Lesion Pattern Was Different According to Antithrombotic Treatment Status in Acute Cardioembolic Stroke
03:00 PM - 07:30 PM Abstract 100 - Cephalocervical Aneurysms Associated with Fibromuscular Dysplasia
03:00 PM - 07:30 PM Abstract 101 - Awareness of Stroke by Nigerians at High Risk
03:00 PM - 07:30 PM Abstract 102 - Modafinil in Post Stroke Fatigue
03:00 PM - 07:30 PM Abstract 103 - The Clinical Features of Late-Onset Poststroke Seizures
03:00 PM - 07:30 PM Abstract 104 - Cocaine Strokes: Are Large Vessel Atherosclerosis and Small Vessel Disease More Prevalent Than Vasospasm?
03:00 PM - 07:30 PM Abstract 105 - Are Stroke Prevention Measures Better Utilized in Primary Stroke Centers?
03:00 PM - 07:30 PM Abstract 106 - Free-Floating Thrombus of the Carotid Artery Detected on Carotid Ultrasound in Patients with Cerebral Infarcts: A 10-Year Study
03:00 PM - 07:30 PM Abstract 107 - Sex Differences in Acute Ischemic Stroke in the Young Adult Population
03:00 PM - 07:30 PM Abstract 108 - Stroke Registry Definitions Lack Consensus across the US
03:00 PM - 07:30 PM Abstract 109 - Factors Predictive of Length of Stay in Acute Ischemic Stroke Patients
03:00 PM - 07:30 PM Abstract 110 - Incidence of Stroke and Stroke-Related Mortality on Ugandan Neurology Ward
03:00 PM - 07:30 PM Abstract 111 - Barriers to Thrombolysis in Acute Ischaemic Stroke
03:00 PM - 07:30 PM Abstract 112 - Concomitant Anterior Circulation Infarction and Age Correlate with Clinical Outcome in Posterior Circulation Strokes
03:00 PM - 07:30 PM Abstract 113 - Currently Used Stroke Registry Definitions Have Poor Inter-Rater Reliability When Compared with ACC Guidelines
03:00 PM - 07:30 PM Abstract 114 - Ischemic Stroke Due to Paradoxical Embolisms in the Hereditary Hemorrhagic Telangiectasia Disease: New Evidence for Repeated Screening and Early Treatment of Pulmonary Arteriovenous Malformations (PAVM). Study of 2 Cases and a Literature Review
03:00 PM - 07:30 PM Abstract 115 - Aspirin Failure in Noncardioembolic Ischemic Stroke: A Retrospective Cohort Study on Its Incidence, Choice of Antiplatelet Treatment and Clinical Outcome
03:00 PM - 07:30 PM Abstract 116 - Heart Rate Variability Changes Occur with MCA Stroke, Related to the Extent of Insular Ischemia
03:00 PM - 07:30 PM Abstract 117 - TGF beta 1 and Acute Ischemic Stroke: The Protective Effect for Stroke Occurrence
03:00 PM - 07:30 PM Abstract 118 - A Systems Approach to Stroke Care: The University Hospitals Cleveland Experience
03:00 PM - 07:30 PM Abstract 119 - Acute Anticoagulation with Intravenous Un-Fractionated Heparin Reduces Early Recurrences in Cardio-Embolic Stroke
03:00 PM - 07:30 PM Abstract 120 - Subclinical Tremor in Normal Controls with vs. without a Family History of Essential Tremor: Data from the United States and Turkey
03:00 PM - 07:30 PM Abstract 121 - Increased Number of Heterotopic Purkinje Cells in Essential Tremor
03:00 PM - 07:30 PM Abstract 122 - Holmes' Tremor: Etiology and Outcome - A Case Series of 37 Patients from the Mayo Clinic
03:00 PM - 07:30 PM Abstract 123 - Embarrassment in Essential Tremor: Discrepancies between Patients and Neurologist-Experts
03:00 PM - 07:30 PM Abstract 124 - Specificity of Purkinje Cell Loss in Essential Tremor
03:00 PM - 07:30 PM Abstract 125 - Depressive Symptoms in Essential Tremor Patients
03:00 PM - 07:30 PM Abstract 126 - Validity and Reliability of Computerized Tremor Spirography as Outcome Measure for Clinical Trials in Essential Tremor
03:00 PM - 07:30 PM Abstract 127 - Long-Term Safety and Efficacy of Pramipexole Extended-Release in Early Parkinson's Disease
03:00 PM - 07:30 PM Abstract 128 - Long-Term Efficacy and Safety of Pramipexole Extended-Release in Advanced Parkinson's Disease: An Open-Label Trial
03:00 PM - 07:30 PM Abstract 129 - Comparison of IPX066, a Novel Extended-Release Oral Carbidopa-Levodopa Formulation, to Immediate-Release Carbidopa-Levodopa in Patients with Advanced Parkinson's Disease (PD)
03:00 PM - 07:30 PM Abstract 130 - Carbidopa/Levodopa Pharmacy Errors in Parkinson's Disease
03:00 PM - 07:30 PM Abstract 131 - Long-Term Treatment of Advanced Parkinson's Disease with Rotigotine
03:00 PM - 07:30 PM Abstract 132 - Three-Year Efficacy and Safety Data for Ropinirole Prolonged Release in Patients with Early Parkinson's Disease
03:00 PM - 07:30 PM Abstract 133 - Open-Label Extension Trial Assessing the Effects of Long-Term Treatment with Rotigotine in Subjects with Early-Stage, Idiopathic Parkinson's Disease: Results from up to 7 Years
03:00 PM - 07:30 PM Abstract 134 - 3,4-Dihydroxyphenylacetaldehyde Research Supports Rasagiline Neuroprotection Found in ADAGIO Study
03:00 PM - 07:30 PM Abstract 135 - A 5-Year Prospective Assessment of Advanced Parkinson's Disease Patients Treated with Subcutaneous Apomorphine Infusion or Subthalamic Nucleus Deep Brain Stimulation
03:00 PM - 07:30 PM Abstract 136 - Adverse Events and Patient Satisfaction Associated with Dopamine Agonist and Levodopa Use for RLS
03:00 PM - 07:30 PM Abstract 137 - Parkinson's Disease and Idiopathic Restless Leg Syndrome
03:00 PM - 07:30 PM Abstract 138 - Quantitative Assessment of Acute L-Dopa Effects on Parkinsonian Dysphagia with Videofluoroscopy
03:00 PM - 07:30 PM Abstract 139 - Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease: Results from a Double-Blind, Sham-Controlled, Randomized, Controlled Trial
03:00 PM - 07:30 PM Abstract 140 - Improvements in Awake Time Spent "On" throughout the Day in Patients with Advanced Parkinson's Disease Treated with Adjunctive Ropinirole Prolonged Release
03:00 PM - 07:30 PM Abstract 141 - Utilizing Intensive-Amplitude Specific Therapeutic Approaches as an Effective Strategy for Improving Functional Mobility in Patients Diagnosed with Parkinson's Disease
03:00 PM - 07:30 PM Abstract 142 - Parkinson Movement Tests Performance: Effects of Acute Medication Challenge on Quantitative Measures in Standard Movement Tests
03:00 PM - 07:30 PM Abstract 143 - Can Large Amplitude Exercise (ThinkBIG) and Nintendo Wii[reg] Game Exercise Offer Parkinson Disease Neuroprotection?
03:00 PM - 07:30 PM Abstract 144 - Parkinson's Disease Patients: Owls or Larks
03:00 PM - 07:30 PM Abstract 145 - Differential Response of Speed, Amplitude, and Rhythm to Dopaminergic Medications in Parkinson's Disease
03:00 PM - 07:30 PM Abstract 146 - Higher Proportion of Responders on the Clinical Global Impression - Improvement Scale with Ropinirole Prolonged Release Compared with Ropinirole Immediate Release in Patients with Advanced Parkinson's Disease
03:00 PM - 07:30 PM Abstract 147 - Improvements in Nocturnal Symptoms with Ropinirole Prolonged Release in Patients with Advanced Parkinson's Disease and with Significant Nocturnal Symptoms Not Optimally Controlled with L-Dopa
03:00 PM - 07:30 PM Abstract 148 - Visuo-Motor Function in Patients with Parkinson's Disease Does Not Improve with Subthalamic Stimulation
03:00 PM - 07:30 PM Abstract 149 - The National Deep Brain Stimulation Brain Tissue Network (DBS-BTN): Preliminary Results
03:00 PM - 07:30 PM Abstract 150 - Brain Micro-Structural Features of Parkinsonian Signs in Very Old Persons: A Diffusion Tensor Imaging Study of the Health Aging and Body Composition (Health ABC) Cohort
03:00 PM - 07:30 PM Abstract 151 - Cortico-Striatal Activity Patterns during a Finger-Movement fMRI Task in Parinson's Disease Patients On and Off Medication
03:00 PM - 07:30 PM Abstract 152 - Deep Brain Stimulation Effects on Cardiovagal Responses in Patients with Parkinson's Disease
03:00 PM - 07:30 PM Abstract 153 - ADC Value of Substantia Nigra in Idiopathic Parkinson's Disease with Unilateral Motor Symptom
03:00 PM - 07:30 PM Abstract 154 - Pallidal Stimulation in Advanced Parkinson's Patients with Contraindications for Subthalamic Stimulation
03:00 PM - 07:30 PM Abstract 155 - Recognition Mismatch of Non-Motor Symptoms in DBS Candidates among Parkinson Patients and Caregivers May Be Scale Driven
03:00 PM - 07:30 PM Abstract 156 - Lesion Rather Than Stimulation: Laterality of Microlesion Impacts Postoperative Verbal Fluency Decline in Subthalamic Deep Brain Stimulation Surgery
03:00 PM - 07:30 PM Abstract 157 - Pediatric Deep Brain Stimulation at Cook Children's Medical Center: 22 Consecutive Cases
03:00 PM - 07:30 PM Abstract 158 - The Unified Multiple System Atrophy Rating Scale (UMSARS) Is Also Suitable To Reveal the Progression of Chinese Multiple System Atrophy Patients
03:00 PM - 07:30 PM Abstract 159 - Autopsy-Proven Progressive Supranuclear Palsy Presenting as Behavioral Variant Frontotemporal Dementia
03:00 PM - 07:30 PM Abstract 160 - A Novel Mutation of CP Genes Inhibits Its Secretion and Causes Aceruloplasminemia
03:00 PM - 07:30 PM Abstract 161 - Concordance for Wilson's Disease Phenotype among Siblings
03:00 PM - 07:30 PM Abstract 162 - Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins: A Preliminary Report
03:00 PM - 07:30 PM Abstract 163 - The Determinants of Disability in Corticobasal Syndrome
03:00 PM - 07:30 PM Abstract 164 - Jaw-Opening Oromandibular Dystonia Secondary to Wilson's Disease - A Preliminary Report of 5 Cases after Use of Botulinum Toxin Type A
03:00 PM - 07:30 PM Abstract 165 - Methyltetrahydrofolate Reductase Gene Polymorphism: A Novel Genetic Factor That Modifies Phenotypic Effects of Copper Toxicity in Wilson's Disease
03:00 PM - 07:30 PM Abstract 166 - Aminopyridines Correct Presymptomatic Neuronal Dysfunction and Improve Late Behavioral and Cellular Phenotype in a Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1)
03:00 PM - 07:30 PM Abstract 167 - Zona Incerta Lesions Affect Striatal Neurochemistry and Behavioural Asymmetry in 6OHDA-Lesioned Rats
03:00 PM - 07:30 PM Abstract 168 - Distinct Roles of GABAergic Interneurons in the Regulation of Striatal Output Pathways
03:00 PM - 07:30 PM Abstract 170 - Post-Mortem Neurochemical Evidence for Decreased Putamen Aldehyde Dehydrogenase in Parkinson Disease
03:00 PM - 07:30 PM Abstract 171 - SEP-228791, a Novel Dopamine and Norepinephrine Re-Uptake Inhibitor, Has Anti-Parkinsonian Actions, without Eliciting Dyskinesia, in the MPTP-Lesioned Primate Model of Parkinson's Disease
03:00 PM - 07:30 PM Abstract 172 - Neurodegenerative Markers in CSF in Patients Suffering from Parkinson's Disease
03:00 PM - 07:30 PM Abstract 173 - Apathy in Multiple Sclerosis and Its Association with Depression, Fatigue and Cognitive Impairment
03:00 PM - 07:30 PM Abstract 174 - Episodic Memory in a Cohort of 395 Multiple Sclerosis Patients
03:00 PM - 07:30 PM Abstract 175 - A Novel Computerized Word-Naming Test Shows That Crossed-Hemisphere Processing Speed Is Slowed in Multiple Sclerosis Patients
03:00 PM - 07:30 PM Abstract 176 - Cognitive and Psychosocial Evaluation of Patients with Benign Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 177 - Ten-Year Trends by Patient-Report Metrics in Multiple Sclerosis Functional and Psychosocial Limitations
03:00 PM - 07:30 PM Abstract 178 - Depression and Fatigue in Clinically Definite Multiple Sclerosis (CDMS, McDonald Criteria) - Results from the Oregon Multiple Sclerosis Registry (OMSR)
03:00 PM - 07:30 PM Abstract 179 - Multiple Sclerosis: EDSS and Disease Duration: Effects on Cognition in a Community Based Study
03:00 PM - 07:30 PM Abstract 180 - Cognitive Impairment in Patients with Clinically Isolated Syndrome: A Reappraisal after 8 Years
03:00 PM - 07:30 PM Abstract 181 - Group Psychotherapy in Patients with Multiple Sclerosis: A Six-Months Study in Groups with Different Disability Scores
03:00 PM - 07:30 PM Abstract 182 - Longitudinal Changes on Self-Report of Cognitive Symptoms on the Perceived Deficits Questionnaire in MS: Correlations with Changes in Neuropsychologic Tests and Depression
03:00 PM - 07:30 PM Abstract 183 - Estimating the Probability of Employment Status Transitions and Exploration of Influential Factors
03:00 PM - 07:30 PM Abstract 184 - Hand Function, Mobility, and Employment Status in the NARCOMS Registry
03:00 PM - 07:30 PM Abstract 185 - Ipsilateral Motor Cortex Activity in RRMS: Compensation or Not?
03:00 PM - 07:30 PM Abstract 186 - Pregnancy Outcomes from the AVONEX[reg] (Interferon beta-1a) Pregnancy Exposure Registry
03:00 PM - 07:30 PM Abstract 187 - An Assessment of Bone Health Lifestyle Factors in MS Patients
03:00 PM - 07:30 PM Abstract 188 - Lack of Congruence in the Ratings of Patients' Health Status by Patients with Multiple Sclerosis and Their Physicians
03:00 PM - 07:30 PM Abstract 189 - Impact of Treatment Adherence on Clinical and Economic Outcomes among Multiple Sclerosis Patients Receiving Disease-Modifying Therapies
03:00 PM - 07:30 PM Abstract 190 - Headache in Multiple Sclerosis. Clinical and Therapeutical Correlations
03:00 PM - 07:30 PM Abstract 191 - Spectrum of Clinical Symptoms in Early MS with Pathologically-Confirmed Cortical Demyelination
03:00 PM - 07:30 PM Abstract 192 - Increasing Macroscopic Pathological Damage in Multiple Sclerosis (MS) Is Associated with More Severe Disease Milestones
03:00 PM - 07:30 PM Abstract 193 - Changes in Circulating Tregs Parallel Reductions in Activated T Cells during Daclizumab Treatment of MS
03:00 PM - 07:30 PM Abstract 194 - Hypereosinophilia with Natalizumab
03:00 PM - 07:30 PM Abstract 195 - In MS Patients, When Should MxA mRNA Be Measured after Interferon-beta Injections?
03:00 PM - 07:30 PM Abstract 196 - Differential Effects of a Selective Sphingosine 1-Phosphate Receptor 1 (S1P1) Modulator (CS-0777) on Circulating Lymphocyte Subsets in Multiple Sclerosis Patients
03:00 PM - 07:30 PM Abstract 197 - Interferon Beta-1a Modulation of B Cells: Implications for Relapsing Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 198 - Effects of Glatiramer Acetate on Proliferation and Differentiation of OLN-93 Cells and Its Interaction with FGF2
03:00 PM - 07:30 PM Abstract 199 - Unusual Development of Progressive Multifocal Leukoencephalopathy with High JC Virus Titer in a Patient with Multiple Sclerosis after 2 Years of Natalizumab Therapy
03:00 PM - 07:30 PM Abstract 200 - In Vitro Whole Blood Monitoring of Biological Response to Type I Interferon Therapy in Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 201 - Intravenous Immunoglobulin (IVIG) in Treatment of Central Pontine and Extrapontine Myelinolysis
03:00 PM - 07:30 PM Abstract 202 - An IL-2 Paradox; Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
03:00 PM - 07:30 PM Abstract 203 - P2X7 Purinergic Receptor on Monocytes of Patients with Multiple Sclerosis: Effects of Glatiramer Acetate Immune Modulation
03:00 PM - 07:30 PM Abstract 204 - Treatment Effects of IFNB-1b on Cognitive Performance in Patients with a First Event Suggestive of MS
03:00 PM - 07:30 PM Abstract 205 - CD161/CCR6 (IL-17 Associated) Expression in Relapsing MS: Effect of Glatiramer Acetate on Immune Regulation
03:00 PM - 07:30 PM Abstract 206 - Systematic Assessment of JC Virus in Multiple Sclerosis Patients Treated with Natalizumab
03:00 PM - 07:30 PM Abstract 207 - Pharmacokinetics of Oral BG-12 Alone Compared with BG-12 and Interferon [beta]-1a or Glatiramer Acetate Administered Together, Studied in Healthy Volunteers
03:00 PM - 07:30 PM Abstract 208 - Laquinimod In Vitro High-Throughput Gene Analysis Reveals Orchestrated Th2 Shift in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 209 - Omega-3 Fatty Acids Treatment in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 210 - Duration Following Severe Attacks of CNS Demyelinating Disease to Plasma Exchange Initiation: How Long Is Too Long?
03:00 PM - 07:30 PM Abstract 211 - Safety and Efficacy of Autologous T-Cell Immunotherapy (Tovaxin) in Patients with Active Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 212 - Synergistic Mechanisms of Fumarate Treatment in CNS Autommunity: Augmenting Axon Protective Effects in Combination Therapies
03:00 PM - 07:30 PM Abstract 213 - Alemtuzumab Reduces Disease Progression in RRMS: Long-Term Results of the CAMMS223 Trial
03:00 PM - 07:30 PM Abstract 214 - Prediction and Characterization of CD56bright NK Cell Expansion during Daclizumab Treatment for Multiple Sclerosis
03:00 PM - 07:30 PM Abstract 215 - Multiple Sclerosis and Other CNS Demyelination after Treatment with Tumor Necrosis Factor alpha Blockers
03:00 PM - 07:30 PM Abstract 216 - Copolymer-1 Shows Neuroprotective Effects Via Peripheral Immunomodulation Rather Than Direct Actions on Neurons
03:00 PM - 07:30 PM Abstract 217 - Cellular and Humoral Influenza Vaccine-Specific Immune Responses in Patients with Multiple Sclerosis Treated with FTY720 or Interferon-beta
03:00 PM - 07:30 PM Abstract 218 - Production of Neurotrophic Factors in MS Patients Treated with Disease Modifying Therapies
03:00 PM - 07:30 PM Abstract 219 - Effects of Cladribine Tablets on Circulating Lymphocyte Subset Reconstitution in the 96-Week CLARITY Study in Relapsing-Remitting Multiple Sclerosis (RRMS)
03:00 PM - 07:30 PM Abstract 220 - Plasmacytoid Denditic Cells (pDC) in Multiple Sclerosis: IFN-[beta] Treatment Inhibits pDC Secretion of Chemokines Specific for CCR5-Positive Th1 Cells
03:00 PM - 07:30 PM Abstract 221 - Decreased Chemokine Directed Migration of Effector Memory T Cells in Fingolimod-Treated Patients
03:00 PM - 07:30 PM Abstract 222 - The Activation of Microglia and Macrophages Is Attenuated by Laquinimod
03:00 PM - 07:30 PM Abstract 223 - Glatiramer Acetate-Reactive T Lymphocytes Regulate Oligodendrocyte Progenitor Cell Number In Vitro
03:00 PM - 07:30 PM Abstract 224 - Predictors of Ventricular Volume in HIV Disease
03:00 PM - 07:30 PM Abstract 225 - Dual Infection with HIV and HCV Has Worse Effects on Cognition Than Infection with HIV Alone
03:00 PM - 07:30 PM Abstract 226 - Utility of HIV-Associated Neuropathy Screening Tools in Western Kenya: Pilot Testing
03:00 PM - 07:30 PM Abstract 227 - Validation of a Novel Computerized Performance-Based Functional Assessment for HIV Associated Neurocognitive Disorders
03:00 PM - 07:30 PM Abstract 228 - Clinical and Cognitive Associations with Midsagittal Corpus Callosum Area in HIV Infected Patients
03:00 PM - 07:30 PM Abstract 230 - Matrix Metalloproteinase-1 Protects Against HIV-1 Tat-Induced Neurotoxicity by Cleavage-Dependent and Cleavage-Independent Mechanisms
03:00 PM - 07:30 PM Abstract 231 - Atrophy in the Medial Temporal Lobes of HIV Patients Is Correlated to ADC Stage
03:00 PM - 07:30 PM Abstract 232 - Gray Matter Volume Loss in HIV Associated Dementia
03:00 PM - 07:30 PM Abstract 233 - Mechanisms of Neurotoxicity Induced by Morphine in the HIV-1 Transgenic Rat
03:00 PM - 07:30 PM Abstract 234 - Utility of a Diagnostic Tool for HIV-Associated Cognitive Impairment in Western Kenya: Pilot Testing
03:00 PM - 07:30 PM Abstract 235 - Pattern of Neuropsychological Performance among HIV-Positive Patients in Kenya
03:00 PM - 07:30 PM Abstract 236 - Prevalence of Seizures in HIV Patients Measured in the Outpatient Setting
03:00 PM - 07:30 PM Abstract 237 - CNS Immune Reconstitution Inflammatory Syndrome (IRIS) in an HIV-Infected Patient with a Stable CD4 Cell Count and Undetectable Viral Load
03:00 PM - 07:30 PM Abstract 238 - Prevalence of HTLV-1 among Selected Cases of Progressive Spastic Non-Compressive Myelopathy in North-Eastern Nigeria
03:00 PM - 07:30 PM Abstract 239 - Progression of Nerve Conduction and EMG Abnormalities in Acute West Nile Virus Infection
03:00 PM - 07:30 PM Abstract 240 - Factors Governing Herpes Simplex Virus Type 1 (HSV-1) Infection of Brain Tissues in Organotypic Cultures
03:00 PM - 07:30 PM Abstract 241 - Encephalitis Associated with Pandemic H1N1-2009: Case Report and Review
03:00 PM - 07:30 PM Abstract 242 - Novel H1N1 Encephalomyelitis
03:00 PM - 07:30 PM Abstract 243 - High Cervical Cord Injury with Posterior Reversible Leukoencephalopathy Syndrome: Case Report
03:00 PM - 07:30 PM Abstract 244 - Focal Hyperhidrosis Due to Irritative Effect of Nerve Root and Spinal Cord Mass Lesions
03:00 PM - 07:30 PM Abstract 245 - Underlying Autonomic Dysfunction in Cough Syncope
03:00 PM - 07:30 PM Abstract 246 - Comorbid Health Conditions in Women with Syncope
03:00 PM - 07:30 PM Abstract 247 - Can Sex Hormone Dysregulation Cause Autonomic Storm?
03:00 PM - 07:30 PM Abstract 248 - The Identification and Characterization of Autonomic Dysfunction in Migraineurs with and without Auras
03:00 PM - 07:30 PM Abstract 249 - Orthostatic and Non-Orthostatic Headache in Postural Tachycardia Syndrome (POTS)
03:00 PM - 07:30 PM Abstract 250 - Menstrual Symptom Alteration in Orthostatic Intolerance, Syncope, and Migraine
03:00 PM - 07:30 PM Abstract 251 - Pregnancy in Postural Tachycardia Syndrome: Clinical Course and Maternal and Fetal Outcomes
03:00 PM - 07:30 PM Abstract 252 - Psychogenic Non-Epileptic Seizures in Postural Orthostatic Tachycardia Syndrome
03:00 PM - 07:30 PM Abstract 253 - Low Iron Storage and Anemia in Adolescents with Postural Tachycardia Syndrome (POTS)
03:00 PM - 07:30 PM Abstract 254 - What Is the Optimal Duration of a Tilt Table Test?
03:00 PM - 07:30 PM Abstract 255 - Cardiac Metaiodobenzylguanidine (cMIBG) Scintigraphy Is a Useful Tool To Access Subclinical Autonomic Involvement in Peripheral Neuropathies
03:00 PM - 07:30 PM Abstract 256 - Catecholaminergic Denervation in the Brain and Heart in Parkinson Disease: Associations with Non-Motor Manifestations
03:00 PM - 07:30 PM Abstract 257 - A Modification to the Quantitative Direct and Indirect Axon Reflex Sudomotor Test (QDIRT) Enhances Test Utility
03:00 PM - 07:30 PM Abstract 258 - Treatment Induced Diabetic Neuropathy - An Acute Reversible Painful Autonomic Neuropathy
03:00 PM - 07:30 PM Abstract 259 - Contamination of the Norepinephrine Pro-Drug Droxidopa by Dihydroxyphenylacetaldehyde
03:00 PM - 07:30 PM Abstract 260 - Pleasant Olfactory Stimulation Enhances Cardiovagal Modulation in Mild Traumatic Brain Injury Patients
03:00 PM - 07:30 PM Abstract 261 - Hematopoietic Cell Transplantation for Adolescent-Onset Cerebral X-Linked Adrenoleukodystrophy
03:00 PM - 07:30 PM Abstract 262 - Prevalence of Somatic and Autonomic Small Fiber Neuropathy in a Cohort of Patients with Inflammatory Bowel Disease (IBD)
03:00 PM - 07:30 PM Abstract 263 - Menstrual Exacerbation in Irritable Bowel Syndrome, Fibromyalgia and Interstitial Cystitis
03:00 PM - 07:30 PM Abstract 264 - Prospective Elderly Human Blood-CNS Biodistribution and Neurocognitive Studies of a Quaternary Amine Antimuscarinic Agent for Overactive Bladder (OAB): The SMART Trial
03:00 PM - 07:30 PM Abstract 265 - Self-Complementary AAV Induces Rapid and Highly Efficient Allotopic Expression of the Human ND4 Complex I Subunit in the Mouse Visual System
03:00 PM - 07:30 PM Abstract 266 - Idiopathic Intracranial Hypertension at a Canadian Tertiary Care Centre
03:00 PM - 07:30 PM Abstract 267 - Neuroretinitis with Bartonella Henselae and EBV Co-Infection: Direct Infection or Immunomodulated Reaction?
03:00 PM - 07:30 PM Abstract 268 - Obstructive Sleep Apnea (OSA) in Idiopathic Intracranial Hypertension (IIH): A Prospective Study
03:00 PM - 07:30 PM Abstract 269 - Neuro-Ophthalmological Implications of CADASIL
03:00 PM - 07:30 PM Abstract 270 - Short Term Adaptation of Visual Search Strategies in Simulated Hemianopia
03:00 PM - 07:30 PM Abstract 271 - Region-Specific Patters of White Matter Diffusivity Changes in Leber's Hereditary Optic Neuropathy: A Tract-Based Spatial Statistics Study
03:00 PM - 07:30 PM Abstract 272 - Retinal Nerve Fibre Layer Thickness and Brain Volume in Acute Optic Neuritis
03:00 PM - 07:30 PM Abstract 273 - Anemia-Dependent Transient Cortical Visual Loss Heralding Acute Myelogenous Leukemia in a Woman with Basilar Stenosis
03:00 PM - 07:30 PM Abstract 274 - Optical Coherence Tomography as Measure of the Effects of Glatiramer Acetate on Axonal Loss in Patients with Acute Optic Neuritis (AON)
03:00 PM - 07:30 PM Abstract 275 - Is Down Slower Than Up? Vertical Saccades in Progressive Supranuclear Palsy (PSP)
03:00 PM - 07:30 PM Abstract 276 - The Usefulness of Bedside Neuro-Otological Examination in Differentiating Central and Peripheral Causes of Isolated Vertigo in Emergency Room
03:00 PM - 07:30 PM Abstract 277 - Vestibular Evoked Neurogenic Potentials Using Air-Conducted Sound: The Discovery of a New Scalp Recorded Potential (N6) That Probably Originates from the Midbrain
03:00 PM - 07:30 PM Abstract 278 - Vestibular Dysfuctions in Migrainous Vertigo Evaluated by Rotatory Chair
03:00 PM - 07:30 PM Abstract 279 - Horizontal Conjugate Gaze Deviation in the Acute Vestibular Syndrome
03:00 PM - 07:30 PM Abstract 280 - Bilateral Synergistic Convergence with Horizontal Gaze Palsy and Scoliosis. Is the Mechanism Supranuclear?
03:00 PM - 07:30 PM Abstract 281 - The Video Head Impulse Test: Diagnostic Accuracy in Peripheral Vestibulopathy
03:00 PM - 07:30 PM Abstract 282 - Acute Encephalopathy, Multiple Ocular Motor Deficits and Bilateral Ptosis Following Embolization of Branches of the External Carotid Artery Feeding a Carotid Body Tumor
03:00 PM - 07:30 PM Abstract 283 - Prosaccade and Antisaccade Performances in Spinocerebellar Ataxia Type 2 and Other Genetic Ataxias
03:00 PM - 07:30 PM Abstract 284 - Cerebral Hemispheric Eye Movement Disorders Are Different in Parkin-Linked and Idiopathic Parkinson's Disease
03:00 PM - 07:30 PM Abstract 285 - Recurrence of Symptoms after Successful Carotid Cavernous Fistula Endovascular Treatment
03:00 PM - 07:30 PM Abstract 286 - The m.3244G[gt]A Mutation in mtDNA Is Another Cause of Progressive External Ophthalmoplegia
03:00 PM - 07:30 PM Abstract 287 - Saccadic Abnormalities in Ocular Myasthenia Reflect Morphological Differences between Neuromuscular Junctions of Extraocular Muscle-Fiber Types
03:00 PM - 07:30 PM Abstract 288 - Prevalence of Clinical Neuro-Ophthalmic Abnormalities in an ALS Cohort
03:00 PM - 07:30 PM Abstract 289 - Ocular Myositis in Crohn's Disease with MRI Imaging Mimicking Thyroid Ophthalmopathy
03:00 PM - 07:30 PM Abstract 290 - Saccade Related Gamma Oscillations Recorded from the Human Basal Ganglia and Thalamus Originate from Ocular Muscles
Faculty Disclosures
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Katherine P. Rankin, PhD The institution of Dr. Rankin has received research support from Marcus Foundation.
Daniel Kaufer, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Alberto J. Espay, MD, FÂ鶹´«Ã½Ó³»­ Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Nancy L. Sicotte, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Sicotte has received research support from PCORI. The institution of Dr. Sicotte has received research support from NIH. The institution of Dr. Sicotte has received research support from NMSS. Dr. Sicotte has a non-compensated relationship as a National Medical Advisory Committee Chair with National MS Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
William Ondo, MD Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Ondo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ondo has received research support from Fascicle. The institution of Dr. Ondo has received research support from Cerevance. The institution of Dr. Ondo has received research support from AskBio. Dr. Ondo has received publishing royalties from a publication relating to health care.
Ruth H. Walker, PhD, MB, ChB Dr. Walker has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc, Inc.. The institution of Dr. Walker has received research support from Department of Veterans Affairs.
Nancy J. Newman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phelcom. The institution of Dr. Newman has received research support from GenSight. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Â鶹´«Ã½Ó³»­ Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' Â鶹´«Ã½Ó³»­ Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical Â鶹´«Ã½Ó³»­. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research Â鶹´«Ã½Ó³»­ Social Awareness and Training In Neurosciences.
Richard B. Lipton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Petra Kaufmann, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kaufmann has received personal compensation for serving as an employee of Affinia Therapeutics. Dr. Kaufmann has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Kaufmann has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for DTx. Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Kaufmann has stock in Vigil Neuroscience. The institution of an immediate family member of Dr. Kaufmann has received research support from Cystic Fibrosis Foundation . Dr. Kaufmann has a non-compensated relationship as a Member of a Scientific Advisory Board with NIH that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Kenneth M. Heilman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Heilman has received publishing royalties from a publication relating to health care.
Peter A. Calabresi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
No disclosure on file
Tagann Chaisam, MD No disclosure on file
Jacqueline Channon-Smith No disclosure on file
Neil Cherian, MD Dr. Cherian has nothing to disclose.
Travis Dunckley, PhD No disclosure on file
Maria V. Alvarez, MD No disclosure on file
Tamar Bacon The institution of an immediate family member of Tamar Bacon has received research support from Novartis. The institution of an immediate family member of Tamar Bacon has received research support from Genentech. An immediate family member of Tamar Bacon has received publishing royalties from a publication relating to health care.
Oren S. Cohen, MD No disclosure on file
Valerie Biousse, MD Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Sebastian F. Ameriso, MD Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Grant Liu, MD, FÂ鶹´«Ã½Ó³»­ Dr. Liu has received publishing royalties from a publication relating to health care.
Stephen D. Silberstein, MD, FÂ鶹´«Ã½Ó³»­ Dr. Silberstein has received publishing royalties from a publication relating to health care.
Constantine Farmakidis, MD, FÂ鶹´«Ã½Ó³»­ Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Regina Berkovich, MD, PhD The institution of Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Biogen, Genentec, Mallincrodt, Sanofi, Novartis, . Dr. Berkovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Genentec, Sanofi, Merck . Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion, Biogen, Sanofi, Merck, Mallincrodt . The institution of Dr. Berkovich has received research support from Biogen, Sanofi, Merck.
Marilou I. Ching, MD Dr. Ching has nothing to disclose.
Andrew P. Duker, MD No disclosure on file
Richard S. Finkel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Simon Israeli-Korn, MD No disclosure on file
Jack P. Antel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Stefania Battistini, MD No disclosure on file
Mefkure Eraksoy, MD Dr. Eraksoy has nothing to disclose.
Bryan Traynor, MD The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care.
Joseph Giuffrida, PhD No disclosure on file
Richard P. Allen, PhD No disclosure on file
Antoni Barrientos No disclosure on file
Maura Brunetti No disclosure on file
Andrea Calvo, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Calvo has nothing to disclose.
Ayman A. Daoud, MD No disclosure on file
Kelly D. Foote, MD Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
M.T. Dotti, MD No disclosure on file
Patricio Brand, MD Dr. Brand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Kallol R. Chaudhuri, MD, FRCP Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acadia, GSK, Scion, Britannia , Lobsor. Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Britannia, Scion, Sunovion, UCB, . Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Britannia, UCB, Zambon. Dr. Chaudhuri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NPJ PD journal. The institution of Dr. Chaudhuri has received research support from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.
Yong Chen, MD No disclosure on file
Anna Czlonkowska, MD Dr. Czlonkowska has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Alexion.
Yessar M. Hussain, MD The institution of Dr. Hussain has received research support from Alnylam Pharma.
Ben M. Illigens, MD Dr. Illigens has received personal compensation for serving as an employee of Target Health. Dr. Illigens has received personal compensation for serving as an employee of BC Platforms. Dr. Illigens has received personal compensation for serving as an employee of NOVA Discovery. Dr. Illigens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RDP Pharma. Dr. Illigens has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Biomind Labs. Dr. Illigens has a non-compensated relationship as a Director with Partners for Patients that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Nelson Hwynn, DO, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Sang-jin Kim, MD No disclosure on file
Giovanni L. Mancardi No disclosure on file
Jennifer J. Manly, PhD The institution of Dr. Manly has received research support from NIH. Dr. Manly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with University of Mississippi.
Dan M. Mungas, PhD Dr. Mungas has nothing to disclose.
Austin Hake, MD No disclosure on file
Cecilia Marelli, MD No disclosure on file
Lionel Naccache No disclosure on file
Murray Grossman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Ilya Kister, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Yang Mao-Draayer, MD Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizone. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Idec. The institution of Dr. Mao-Draayer has received research support from NIH .
Robert A. Hauser, MD, MBA, FÂ鶹´«Ã½Ó³»­ Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Clair M. Cascella, MD No disclosure on file
Cathy A. Sila, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sila has nothing to disclose.
Ingrid K. Bjorna, MD No disclosure on file
Alla Nikolajeuna Ser Bru No disclosure on file
Atbin Djamshidian No disclosure on file
Adam B. Edwards, MD Dr. Edwards has nothing to disclose.
Sol M. Cavanagh Campos, MD Dr. Cavanagh Campos has nothing to disclose.
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Kimiko Domoto-Reilly, MD Dr. Domoto-Reilly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedBridge. The institution of Dr. Domoto-Reilly has received research support from Lawson Health Research Institute. The institution of Dr. Domoto-Reilly has received research support from NIH. The institution of Dr. Domoto-Reilly has received research support from Biogen. The institution of Dr. Domoto-Reilly has received research support from Lewy Body Dementia Association. The institution of Dr. Domoto-Reilly has received research support from Garvey Institute for Brain Health Solutions. The institution of Dr. Domoto-Reilly has received research support from Cognition Therapeutics. The institution of Dr. Domoto-Reilly has received research support from Takayama Family.
Lauren B. Elman, MD Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Elman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharamaceuticals. Dr. Elman has received publishing royalties from a publication relating to health care.
Michael Calloway No disclosure on file
Anna Feldman No disclosure on file
Angeline Ngo, MD Dr. Ngo has nothing to disclose.
J. David Avila, MD, FÂ鶹´«Ã½Ó³»­ Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Caroline Bensa Caroline Bensa has nothing to disclose.
Beau B. Bruce, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bruce has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bayer.
Tanis J. Ferman, PhD Ms. Ferman has nothing to disclose.
Suzanne Forrest No disclosure on file
Wolfgang Heide, MD, FEAN No disclosure on file
Yong S. Lee, MD No disclosure on file
Patrick M. Grogan, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Antoine Gueguen, MD An immediate family member of Dr. Gueguen has received personal compensation for serving as an employee of ABBVIE. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Jonhson&Jonhson. Dr. Gueguen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson. The institution of Dr. Gueguen has received research support from BrainEver. The institution of Dr. Gueguen has received research support from Pixyl. The institution of Dr. Gueguen has received research support from Kalsiom. The institution of Dr. Gueguen has received research support from Ministére de la Santé, France.
Hui Huang, MD, PhD No disclosure on file
Cynthia Joyce No disclosure on file
Mark F. Lew, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH.
Terrence M. Li, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Ranjani Manjunath, MSPH No disclosure on file
Leo McCluskey, MD No disclosure on file
Heather Moss, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Michael Gurevich No disclosure on file
Dustin A. Heldman, PhD Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
Rachel L. Higbie, BA No disclosure on file
Huana C. Marin, MD No disclosure on file
Jennifer Michaels, MD No disclosure on file
Cristina Moglia Cristina Moglia has nothing to disclose.
Jacob Kitchener, MD No disclosure on file
Inna Kleyman, MD Dr. Kleyman has nothing to disclose.
Shashidhar Kori, MD Dr. Kori has received personal compensation for serving as an employee of Novilla Pharma. Dr. Kori has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Satsuma Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Tonix Pharma. Dr. Kori has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Exalys Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for NewBio Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for Afsci Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Trigemina Inc. Dr. Kori has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Novilla Pharma. Dr. Kori has received stock or an ownership interest from Novilla Pharma. Dr. Kori has received stock or an ownership interest from NewBio Pharma. Dr. Kori has received stock or an ownership interest from Tonix Pharma. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Reviewer of grant applications with Department of Defense.
Abhay Kumar, MD Dr. Kumar has nothing to disclose.
Vladimir Hachinski, MD, DSc, FÂ鶹´«Ã½Ó³»­ Dr. Hachinski has nothing to disclose.
Keith A. Josephs, Jr., MD, FÂ鶹´«Ã½Ó³»­ Dr. Josephs has nothing to disclose.
Frederik Barkhof, MD, PhD Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Reem F. Bunyan, MD No disclosure on file
Pasquale Calabrese, PhD Dr. Calabrese has nothing to disclose.
Mark Hallett, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Michael G. Halmagyi, MD Dr. Halmagyi has nothing to disclose.
Virginia A. Devonshire, MD Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck- Serono. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen . Dr. Devonshire has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for novartis. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for roche. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biogen .
Sharon Hassin-Baer, MD Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDISON. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA.
Trina Johnson, MD No disclosure on file
Sushant P. Kale, MD No disclosure on file
Pierre Lecanuet No disclosure on file
Aryn Gittis No disclosure on file
Jessica Mandrioli No disclosure on file
Steven Z. Rapcsak, MD Dr. Rapcsak has nothing to disclose.
Gulden Akdal, MD Dr. Akdal has nothing to disclose.
Leslie C. Baxter, PhD No disclosure on file
Athena L. Chen No disclosure on file
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Pamela Federighi No disclosure on file
Mirla L. Avila, MD, FÂ鶹´«Ã½Ó³»­ Dr. Avila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Genzyme, BMS, Serono. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen, genzyme, BMS. The institution of Dr. Avila has received research support from Texas Tech.
Thomas O. Crawford, MD Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Emily Dunn No disclosure on file
Andreas J. Plaitakis, MD No disclosure on file
Ilaria Bartolomei No disclosure on file
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Ashley Boller No disclosure on file
Karen Chen, PhD No disclosure on file
James Cooper, PhD Dr. Cooper has received personal compensation for serving as an employee of GSK. Dr. Cooper has stock in GSK.
Howard A. Crystal, MD, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Crystal has received personal compensation for serving as an employee of C4 TherAPEUTICS. An immediate family member of Dr. Crystal has stock in c4 THERAPEUTICS. Dr. Crystal has stock in c4 THERAPEUTICS.
Sophie Drapier, MD No disclosure on file
Mark J. Kupersmith, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kupersmith has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal firms. Dr. Kupersmith has stock in SafeTherapeutics m,LLC. The institution of Dr. Kupersmith has received research support from NEI, NYEEI FDN, Shulman Family NAION fund. Dr. Kupersmith has received intellectual property interests from a discovery or technology relating to health care.
Lisa L. Baumbach-Reardon, PhD, FACMG No disclosure on file
Adriano Chio, MD, FÂ鶹´«Ã½Ó³»­ Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Georgia M. Davies No disclosure on file
Alberto L. Dubrovsky, MD No disclosure on file
Maria del Pilar Guillermo Prieto Eibl, MD Dr. Guillermo Prieto Eibl has nothing to disclose.
Ihtsham Haq, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Rivka Inzelberg, MD No disclosure on file
Mounzer Kassab, MD No disclosure on file
Marcelo C. Kremenchutzky, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Francois Lallement No disclosure on file
Alan Lipschitz, MD No disclosure on file
Justin C. McArthur, MBBS, MPH, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Yi-Chung Lee, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Lee has received research support from National Science and technology Council Taiwan . The institution of Dr. Lee has received research support from Taipei Veterans General Hospital Taiwan.
Waldo Guerrero, MD Dr. Guerrero has nothing to disclose.
Mechele Lee No disclosure on file
Alexandra J. Sequeira, MD Dr. Sequeira has nothing to disclose.
Antoine Moulignier, MD No disclosure on file
George J. Hutton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hutton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Autoimmunity Biologic Solutions, Inc.. The institution of Dr. Hutton has received research support from Biogen. The institution of Dr. Hutton has received research support from Genentech. The institution of Dr. Hutton has received research support from Genzyme.
Howard Aizenstein, MD, PhD No disclosure on file
Paolo Barone, MD No disclosure on file
Susan C. Byrne, MD No disclosure on file
Anna D. Hohler, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hohler has nothing to disclose.
Harald Olav Hovdal, MD No disclosure on file
Hahn Young Kim No disclosure on file
Stephen J. Kolb, MD, PhD Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Vikas Kotagal, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.
Gilles Edan, MD No disclosure on file
Suneel K. Gupta, PhD No disclosure on file
Joanna Hellmuth, MD Dr. Hellmuth has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McAngus Goudelock & Courie law firm.
Fumio Kanda, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Hye-Jin J. Kim No disclosure on file
Ja-Seong Koo, MD No disclosure on file
Olaf Henriksen No disclosure on file
Brendan J. Kelley, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Labcorp. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai.
Massimo Pandolfo, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Caterina Rosano, MD, MPH No disclosure on file
Latt Latt Aung, MD No disclosure on file
Peii Chen No disclosure on file
Stefania Corti, MD, PhD Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Corti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
Astrid Edland, MD No disclosure on file
Raphael Hourez, MD, PhD No disclosure on file
Sucjoo Kim, MD No disclosure on file
Jau-Shin Lou, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Lou has nothing to disclose.
Natalia Murinova, MD, FÂ鶹´«Ã½Ó³»­ Dr. Murinova has nothing to disclose.
Kjell Morten Myhr, MD No disclosure on file
Camila Pupe, MD Dr. Pupe has nothing to disclose.
Anthony J. Furlan, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Georg A. Hishaw, MD No disclosure on file
Jung-Ju Lee, MD, PhD No disclosure on file
Ada Francia, MD No disclosure on file
Hans-Peter Hartung, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Jill T. Jesurum, PhD No disclosure on file
Gisa Ellrichmann No disclosure on file
Brian Grosberg, MD Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma pharmaceuticals. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theranica . Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Grosberg has stock in Theranica. The institution of Dr. Grosberg has received research support from Theranica. The institution of Dr. Grosberg has received research support from Amgen. The institution of Dr. Grosberg has received research support from Abbvie. The institution of Dr. Grosberg has received research support from Eli Lilly. The institution of Dr. Grosberg has received research support from Teva. The institution of Dr. Grosberg has received research support from Neurolief. Dr. Grosberg has received publishing royalties from a publication relating to health care.
Maya L. Henry, PhD No disclosure on file
Regina Lam No disclosure on file
Daniel Bandari, MD The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. The institution of Dr. Bandari has received research support from Genentech. The institution of Dr. Bandari has received research support from EMD-Serono.
Antonie G. Beiske Gjaever No disclosure on file
Archit Bhatt, MD No disclosure on file
Randi Eikeland, MD No disclosure on file
Jacob S. Elkins, MD No disclosure on file
Andrew H. Evans, MB, BS Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stada. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seqirus. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stada. The institution of Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Seqirus. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bluerock. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Encapsulate.
Nosheen J. Rafique No disclosure on file
Kyung-Wook Kang, MD No disclosure on file
Ludwig Kappos, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kappos has nothing to disclose.
Sherron H. Kell, MD No disclosure on file
Nasim R. Khadem No disclosure on file
Grethe Kleveland, MD No disclosure on file
Kyung-Bok Lee, MD No disclosure on file
Logan McDaneld, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Xavier Montalban, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Rita M. Nilsen No disclosure on file
Joseph E. Parisi, MD Dr. Parisi has nothing to disclose.
Richard M. Ransohoff, MD Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care.
Sjur Reinertsen No disclosure on file
Markus Krumbholz Markus Krumbholz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme, Merck, Novartis, Roche. The institution of Markus Krumbholz has received research support from Merck.
Hyon S. Kim, MD No disclosure on file
Elizabeth Dragan, MD No disclosure on file
Muhammad Farooq, MD Dr. Farooq has nothing to disclose.
Shizuo Hatashita, MD, PhD No disclosure on file
Dong-wha Kang, MD No disclosure on file
Ohyun Kwon No disclosure on file
Giuseppe Lanzino, MD Dr. Lanzino has nothing to disclose.
Ju-Hun Lee, MD No disclosure on file
Thomas C. Chelimsky, MD Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Proctor & Gamble. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Various Legal Firms. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Legal Firms. Dr. Chelimsky has received stock or an ownership interest from PainSTakers, LLC. The institution of Dr. Chelimsky has received research support from NIDDK. The institution of Dr. Chelimsky has received research support from Advancing a Healthier Wisconsin.
Nereo Bresolin, DR No disclosure on file
Teresa Caloto, PhD No disclosure on file
Raymond T. Cheung, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Ann F. Hsu, PhD, PharmD No disclosure on file
Halfdan Kierulf, MD No disclosure on file
Andrew J. Lees, MD, FRCP Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Britannia. Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Bial Pharma.
Stewart H. Mostofsky, MD No disclosure on file
Osvaldo J. Nascimento, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Nascimento has nothing to disclose.
Shanu Roemer Shanu Roemer has nothing to disclose.
Mohammad Fouladvand, MD No disclosure on file
Mark S. Freedman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Laurence J. Kinsella, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kinsella has received publishing royalties from a publication relating to health care.
Henry J. Kaminski, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Hossein Ansari, MD, FÂ鶹´«Ã½Ó³»­ Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NOEMA Pharmaceutical . Dr. Ansari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BIOHAVEN Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioDelivery Sciences International, Inc. . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Ansari has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MedLegal Network. Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Litogation Legal insight ( LITILI). Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FOLAND, WICKENS, ROPER, HOFER & CRAWFORD, P.C.
Olivier Beauchet, MD, PhD No disclosure on file
Kaoutar El Hafsi No disclosure on file
Robert D. Fealey, MD No disclosure on file
Jae Wond Jang, MD No disclosure on file
Jacqueline Montes, PT, EdD, NCS Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Amber Salter, PhD Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Stuart R. Tomko, MD No disclosure on file
Valdimir Vexler No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
David E. Newman-Toker, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Newman-Toker has received research support from NIH, AHRQ, AHA, Moore Foundation. Dr. Newman-Toker has received intellectual property interests from a discovery or technology relating to health care.
John Pula, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pula has nothing to disclose.
Klaus Kallenbach No disclosure on file
Iyavut Thaipisuttikul, MD No disclosure on file
Po-Heng Tsai, MD No disclosure on file
Paola Sandroni, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Sandroni has nothing to disclose.
Fernando Acosta, MD No disclosure on file
Darryl C. De Vivo, MD, FÂ鶹´«Ã½Ó³»­ Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Deborah Forst, MD Dr. Forst has stock in Eli Lilly. Dr. Forst has received research support from Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Forst has received research support from Palliative Care Research Cooperative Group. Dr. Forst has received research support from American Cancer Society Institutional Research Grant.
Jyh-Gong G. Hou, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Joanna C. Jen, MD, PhD Dr. Jen has nothing to disclose.
Sarah Kremen, MD Dr. Kremen has received publishing royalties from a publication relating to health care.
Tina C. Lin, DO No disclosure on file
Werner Poewe, MD Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Laurence Salin Laurence Salin has received personal compensation for serving as an employee of NeuroDerm.
Jun Shimizu, MD, PhD No disclosure on file
Jawad Bajwa, MD No disclosure on file
Haruhiko Banno, MD No disclosure on file
Pratik D. Bhattacharya, MD, MPH Dr. Bhattacharya has a non-compensated relationship as a Research Advisor with Defeat MSA Alliance 501 (c) (3) that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Alan Carpenter, PhD No disclosure on file
Kathrin LaFaver, MD, FÂ鶹´«Ã½Ó³»­ Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. LaFaver has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for WALL, WALL & FRAUENHOFER, LLP. The institution of Dr. LaFaver has received research support from Ayers Foundation. Dr. LaFaver has received publishing royalties from a publication relating to health care. Dr. LaFaver has a non-compensated relationship as a Board Member with FND Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. LaFaver has a non-compensated relationship as a Medical Advisor with FND Hope that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
David S. Goldstein, MD, PhD Dr. Goldstein has received publishing royalties from a publication relating to health care.
Simona Pontecorvo No disclosure on file
Lucas Restrepo, MD, PhD Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
David H. Snyder, MD No disclosure on file
Douglas M. Sproule, MD Dr. Sproule has received personal compensation for serving as an employee of Bridge Bio. Dr. Sproule has received personal compensation for serving as an employee of Novartis, Inc. Dr. Sproule has received stock or an ownership interest from Bridge Bio.
Terje Kristensen No disclosure on file
Sun U. Kwon, MD No disclosure on file
Asa Cordle No disclosure on file
Anhar Hassan, MBBCH, FRACP, FRCPI, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Hassan has received research support from Intrabio . Dr. Hassan has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Korean Movement Disorders Society.
Myeong-Kyu Kim No disclosure on file
JeeHyun Kwon, MD No disclosure on file
Kathleen Currey No disclosure on file
H. E. Hinson, MD, MCR, FÂ鶹´«Ã½Ó³»­ Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Froeydis Dalene No disclosure on file
Cindy Fuller No disclosure on file
Mark Gorman, MD The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Dietrich Haubenberger, MD, FÂ鶹´«Ã½Ó³»­ Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Dong-eog Kim, MD No disclosure on file
Wei Liu, MD Dr. Liu has nothing to disclose.
Ramesh Khurana, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Roxanne L. Julius No disclosure on file
Wendy M. King, PT Ms. King has nothing to disclose.
Hisatomo Kowa, MD, PhD No disclosure on file
Megan Montgomery No disclosure on file
Violaine Plante-Bordeneuve, MD Dr. Plante-Bordeneuve has nothing to disclose.
J. D. Bartleson, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bartleson has nothing to disclose.
William P. Cheshire, Jr., MD, FÂ鶹´«Ã½Ó³»­ Dr. Cheshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for oxford university press. Dr. Cheshire has a non-compensated relationship as a Associate Editor with Clinical Autonomic Research that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Kirk R. Daffner, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM.
Cedric Annweiler, MD, PhD No disclosure on file
Tae-Kyeong Lee, MD No disclosure on file
Rebecca Spain, MD, MSPH, FÂ鶹´«Ã½Ó³»­ Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Ole Suhr The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam . The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akces. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Akcea. The institution of Ole Suhr has received research support from Swedish Heart and Lung Foundation.
Edmond Teng, MD, PhD Dr. Teng has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Teng has received personal compensation for serving as an employee of Evidation Health. Dr. Teng has stock in F. Hoffman-La Roche. An immediate family member of Dr. Teng has stock in Evidation Health. Dr. Teng has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Teng has received intellectual property interests from a discovery or technology relating to health care.
Elan D. Louis, MD, MS, FÂ鶹´«Ã½Ó³»­ Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Susan B. Bressman, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Kristi M. Nord, MD No disclosure on file
Helene Brissart No disclosure on file
Paul Edison, MBBS, PhD, FRCPI No disclosure on file
Richard F. Holub, MD No disclosure on file
Jorge C. Kattah, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Aaron E. Miller, MD, FÂ鶹´«Ã½Ó³»­ Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Nancy Hammond, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hammond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Healthline.
Jonathan M. Brotchie, PhD No disclosure on file
Johanna L. Morton, MD, MS Dr. Morton has received personal compensation for serving as an employee of SOC Telemed. Dr. Morton has received personal compensation for serving as an employee of The Joint Commission.
Jee Hoon Roh, MD, PhD No disclosure on file
Rodolfo Savica, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Anthony Schapira No disclosure on file
Mark J. Tullman, MD Dr. Tullman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Tullman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Viela Bio.
Alexandra Nelson, MD, PhD No disclosure on file
Aleksandra C. Stark-Laudate, MD Dr. Stark-Laudate has nothing to disclose.
Jennifer E. Vaughan, MD No disclosure on file
Roberto Prado, MD, PhD No disclosure on file
Gabriele Siciliano Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Open Health. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Gabriele Siciliano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Grifols. The institution of Gabriele Siciliano has received research support from Biogen.
Janet C. Rucker, MD Dr. Rucker has nothing to disclose.
Enrico S. Bertini, MD Dr. Bertini has received personal compensation for serving as an employee of Bambino Gesu' Children's Resesarch Hospital.
Miguel Bussiere, MD, PhD No disclosure on file
Adele D'Amico No disclosure on file
Burk Jubelt, MD No disclosure on file
James Moberly No disclosure on file
Paula D. Ravin, MD No disclosure on file
Aimee Szewka, MD, FÂ鶹´«Ã½Ó³»­ Dr. Szewka has nothing to disclose.
Gabriele Mora, MD Dr. Mora has nothing to disclose.
Peter P. Pramstaller, MD No disclosure on file
Andrew Resnick, BS No disclosure on file
Tiphaine Rouaud No disclosure on file
Susan Fox, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care.
Frederic Assal, MD Dr. Assal has nothing to disclose.
Amanda A. Forys, MSPH No disclosure on file
Haitham Hussein, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hussein has nothing to disclose.
Richard Levy Richard Levy has nothing to disclose.
Ashwini K. Rao No disclosure on file
Katherine A. Riester, MPH No disclosure on file
Lars Wojtecki, MD, PhD No disclosure on file
Tjalf Ziemssen, MD, FÂ鶹´«Ã½Ó³»­ Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Osama Sabri, MD, PhD No disclosure on file
Suratno Sastro Sukarno, MD No disclosure on file
Evangelia Sotiriou, MD No disclosure on file
Martin Berghoff, MD, FÂ鶹´«Ã½Ó³»­ Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MerckSerono. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
P. Murali Doraiswamy No disclosure on file
Tulay Kansu, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Rola Khedraki No disclosure on file
Michael W. Lenihan, MD No disclosure on file
Scott McGinnis, MD Dr. McGinnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Cornelia Mihai, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mihai has nothing to disclose.
Rachel L. Moreau No disclosure on file
Sun Ah Park, MD No disclosure on file
Mehul P. Sampat, PhD No disclosure on file
Rebecca Traub, MD, FÂ鶹´«Ã½Ó³»­ Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. The institution of Dr. Traub has received research support from Alnylam Pharmaceuticals. The institution of Dr. Traub has received research support from Muscular Dystrophy Association (MDA). The institution of Dr. Traub has received research support from Ionis. The institution of Dr. Traub has received research support from Argenx. The institution of Dr. Traub has received research support from Pharnext. The institution of Dr. Traub has received research support from Immunovant. The institution of Dr. Traub has received research support from Takeda. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a consultant with Department of Justice.
Edward Fox, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Mario F. Mendez, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Â鶹´«Ã½Ó³»­ Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Fred D. Lublin, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Maiya Geddes, MD No disclosure on file
Gilles Allali, MD, PhD Dr. Allali has nothing to disclose.
Eduardo E. Benarroch, MD, FÂ鶹´«Ã½Ó³»­ Dr. Benarroch has nothing to disclose.
Sally Dunaway, DPT Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Dunaway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cure SMA. The institution of Dr. Dunaway has received research support from Cure SMA. The institution of Dr. Dunaway has received research support from Scholar Rock. The institution of Dr. Dunaway has received research support from Ionis Pharmaceuticals.
Eugene C. Lai, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Lai has received publishing royalties from a publication relating to health care.
James F. Paskavitz, MD No disclosure on file
Allan Perel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Perel has received personal compensation for serving as an employee of Abbvie. The institution of Dr. Perel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Perel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Mattea L. Tan No disclosure on file
Mathieu Vokaer, MD No disclosure on file
Devon Conway, MD Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Robert B. Daroff, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Gabrielle Glick No disclosure on file
Kerry Hamsher, PhD No disclosure on file
Laura Herbelin No disclosure on file
Laila K. Jarjour, MB ChB MPH No disclosure on file
Joseph S. Kass, MD, JD, FÂ鶹´«Ã½Ó³»­ Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­ . Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Kass has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple Law Firms . Dr. Kass has received publishing royalties from a publication relating to health care.
Carol Moore No disclosure on file
Laura Allen, NP Ms. Allen has nothing to disclose.
James T. Becker, PhD No disclosure on file
William J. Burke, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Chi-Chao Chao Chi-Chao Chao has nothing to disclose.
Michael Chilungu, MD No disclosure on file
Ahmed El-Dokla, MD, FÂ鶹´«Ã½Ó³»­ Dr. El-Dokla has nothing to disclose.
Phyllis Faust Phyllis Faust has nothing to disclose.
Vera Fridman, MD Dr. Fridman has nothing to disclose.
Dawn McGuire, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Marcello Naccarato No disclosure on file
Jelena M. Pavlovic, MD, PhD Dr. Pavlovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Pavlovic has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Francesco Marrosu, MD No disclosure on file
Adeline Vanderver, MD, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Steven K. Feske, MD Dr. Feske has received publishing royalties from a publication relating to health care.
Mickael Cohen No disclosure on file
Warren Marks, MD No disclosure on file
Peter Novak, MD Dr. Novak has received personal compensation for serving as an employee of Dysimmune Disease Foundation. Dr. Novak has stock in Pfeizer. Dr. Novak has stock in Moderna. Dr. Novak has stock in Novavax. Dr. Novak has stock in Editas Medicine. Dr. Novak has stock in Prothena. Dr. Novak has received publishing royalties from a publication relating to health care.
Mark Gudesblatt, MD The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Jill M. Marjama-Lyons, MD No disclosure on file
Kristina Martinu No disclosure on file
Mamatha Pasnoor, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Alexander H. Rajput, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rajput has received personal compensation in the range of $500-$4,999 for serving as a Peer reviewer with CQDM.
Lisa M. Shulman, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Phyllis C. Zee, MD, PhD Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apnimed. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for World Sleep Society. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Brain Foundation. An immediate family member of Dr. Zee has stock in Teva. An immediate family member of Dr. Zee has stock in Pfizer. The institution of Dr. Zee has received research support from National Institutes of Health. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care.
Clyde E. Markowitz, MD No disclosure on file
Teresa J. Buracchio, MD No disclosure on file
Alice Favaretto No disclosure on file
Gareth R. John No disclosure on file
Peter A. LeWitt, MD Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
Bruno C. Musch, MD No disclosure on file
Martin Nevrly, MD No disclosure on file
Aren Okello No disclosure on file
Timna Onigman No disclosure on file
Nishant S. Ranawat, MD No disclosure on file
Sandra Ruby, MD No disclosure on file
Sara A. Simpson, MD No disclosure on file
Jerzy P. Szaflarski, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Karen C. Albright, DO, DO, PhD, MS, MPH Dr. Albright has nothing to disclose.
Carlo Avolio, MD No disclosure on file
Svetlana Blitshteyn, MD, FÂ鶹´«Ã½Ó³»­ Dr. Blitshteyn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Blitshteyn has received publishing royalties from a publication relating to health care. Dr. Blitshteyn has received personal compensation in the range of $500-$4,999 for serving as a Healthcare Expert with Agency for Healthcare Quality and Research, US Health and Human Services.
James E. Galvin, MD, MPH Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Ioannis U. Isaias, MD Dr. Isaias has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Newronika. Dr. Isaias has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Isaias has stock in Newronika. Dr. Isaias has received research support from Fondazione Grigioni per il Morbo di Parkinson. The institution of Dr. Isaias has received research support from Fresco Parkinson Institute Italia Onlus. The institution of Dr. Isaias has received research support from Deutsche Forschungsgemeinschaft.
Imad T. Jarjour, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Jens Kuhle, MD Dr. Kuhle has nothing to disclose.
Ali H. Rajput, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Sean I. Savitz, MD Dr. Savitz has nothing to disclose.
Mustafa Ertas No disclosure on file
Alida F. Griffith, MD No disclosure on file
Amie L. Hiller, MD The institution of Dr. Hiller has received research support from Admas Pharmaceuticals.
Tom H. Johnston, PhD No disclosure on file
Belen Pascual, PhD The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Liliana Robles, MD No disclosure on file
Gen Sobue, MD Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nippon Chemiphar Co., Ltd.. Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Takeda Pharmaceutical Company Limited..
Youn Young Chul, MD No disclosure on file
David H. Miller, MD, MBChB, FRCP No disclosure on file
Shrikant Mishra, MD Dr. Mishra has nothing to disclose.
Shiho Okuda, MD No disclosure on file
Anmar Razak, MD Dr. Razak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals.
Ana-Luiza Sayao, MD Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Arun Sundaram, MD, FRCP No disclosure on file
Pablo Martinez-Lage, MD No disclosure on file
Panayiotis Mitsias, MD The institution of Dr. Mitsias has received research support from European Union.
Gereon Nelles, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Memodio. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industrial. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for German Neurologists Professional Organization. Dr. Nelles has received publishing royalties from a publication relating to health care.
Ji-Young Park, MD No disclosure on file
Christoph J. Schankin, MD The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grünenthal. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Schankin has stock in Zynnon.
James Sheridan, PhD No disclosure on file
Israel Steiner, MD No disclosure on file
Christoph Pohl, MD No disclosure on file
David E. Riley, MD Dr. Riley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen.
Vahid Tohidi, MD, PhD Dr. Tohidi has nothing to disclose.
Ruth H. Whitham, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Richard Wise No disclosure on file
Tomotaka Yamamoto No disclosure on file
Per Soelberg Sorensen No disclosure on file
Jason Barton, MD, PhD, FRCPC The institution of Dr. Barton has received research support from Canada research Chair. Dr. Barton has received publishing royalties from a publication relating to health care. Dr. Barton has received personal compensation in the range of $500-$4,999 for serving as a guideline for vision therapy in MTBI with ICBC.
Walter R. Royal III, MD No disclosure on file
Aninda Acharya, MD Dr. Acharya has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Acharya has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Acharya has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Brian R. Apatoff, MD, PhD No disclosure on file
Leonardo De Souza No disclosure on file
Ramon R. Diaz-Arrastia, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Wayne W. Feng, MD, FÂ鶹´«Ã½Ó³»­ Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen.
Joseph Y. Matsumoto, MD Dr. Matsumoto has nothing to disclose.
Arshad Majid, MD Dr. Majid has received publishing royalties from a publication relating to health care.
Shira Markowitz, MD No disclosure on file
Scott Millis Scott Millis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor & Francis. The institution of Scott Millis has received research support from NIH & NIDILRR.
Babak Movassaghi, MD No disclosure on file
Huma Sheikh, MD Dr. Sheikh has nothing to disclose.
Fatta B. Nahab, MD, FÂ鶹´«Ã½Ó³»­ Dr. Nahab has received personal compensation for serving as an employee of Neuron23. Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Nahab has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ActualSignal. Dr. Nahab has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Attune Neurosciences, Inc.. Dr. Nahab has stock in Biogen. Dr. Nahab has received personal compensation in the range of $500-$4,999 for serving as a DSMB Member with NIH.
Matthew J. Ostrander, MD No disclosure on file
Timothy J. Steiner No disclosure on file
Jesus Lovera, MD Dr. Lovera has nothing to disclose.
Rune Midgard, MD No disclosure on file
Jong-Moo Park, MD No disclosure on file
Maria C. Polidori, MD No disclosure on file
Laurent Servais Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evox. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Joseph Jankovic, MD, FÂ鶹´«Ã½Ó³»­ Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Daniel R. Wynn, MD Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Sandra E. Black, MD, FÂ鶹´«Ã½Ó³»­ Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Limited . Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Black has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Black has received research support from Hoffmann-La Roche. The institution of Dr. Black has received research support from Biogen. The institution of Dr. Black has received research support from GE Healthcare. The institution of Dr. Black has received research support from Eli Lilly. The institution of Dr. Black has received research support from Genentech. The institution of Dr. Black has received research support from NovoNordisk. The institution of Dr. Black has received research support from UCB Biopharma. The institution of Dr. Black has received research support from Alkahest Inc. The institution of Dr. Black has received research support from University of Southern California - AHEAD 3-45 Study.
Dani Cabral, MD No disclosure on file
Philip Cherian, MD No disclosure on file
Bruce A. Cohen, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. The institution of Dr. Cohen has received research support from Genentech. The institution of Dr. Cohen has received research support from MedDay. The institution of Dr. Cohen has received research support from Consortium of Multiple Sclerosis Centers.
Angel Golimstok No disclosure on file
Diane L. Ito, MA No disclosure on file
Irwin J. Kopin, MD No disclosure on file
Vijay B. Kumar No disclosure on file
Sheryl Martin-Schild, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
W. Michael Panneton, PhD No disclosure on file
Gilberto Pizzolato, MD No disclosure on file
Michele L. Rajput No disclosure on file
Zimbul Albo-Angelus, MD, PhD No disclosure on file
William D. Arnold, MD Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
H. Bockholt No disclosure on file
Maria C. Fernandez, MD Dr. Fernandez has nothing to disclose.
Tea Fevr No disclosure on file
Penelope Hogarth, MD No disclosure on file
Alan Lerner, MD The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Sven G. Meuth Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Yakub W. Nyandaiti, MBBS No disclosure on file
Juha O. Rinne, MD, PhD No disclosure on file
Alfred T. Frontera, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Vera Novak, MD No disclosure on file
Ji-Yun Park No disclosure on file
Massimiliano Prencipe, MD No disclosure on file
Olivier Rascol, MD, PhD Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Matthias Maschke, MD No disclosure on file
Sean S. O'Sullivan, MD No disclosure on file
Laura N. Pirra No disclosure on file
Kumar Rajamani, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rajamani has nothing to disclose.
Luis F. Maia No disclosure on file
Jayawant N. Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
Michele Mass, MD No disclosure on file
Marios Pantzaris, MD Dr. Pantzaris has nothing to disclose.
Chris H. Polman, MD No disclosure on file
Rupert Sandbrink, MD, PhD Dr. Sandbrink has received personal compensation for serving as an employee of Topas Therapeutics. Dr. Sandbrink has received personal compensation for serving as an employee of Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Forward Pharma. Dr. Sandbrink has received stock or an ownership interest from Topas Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Bayer.
Seung-Han Lee, MD, PhD Dr. Lee has nothing to disclose.
Joel J. Oger, MD, FRCPC, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Savvas S. Papacostas, DO, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Siddharama Pawate, MD The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen.
Kenneth J. Shulman, DO No disclosure on file
Andreas Straube Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis.
Devraj Sukul No disclosure on file
Venkata Mattay, MD No disclosure on file
Chiara Monaldini No disclosure on file
Melissa J. Nirenberg, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Nirenberg has received research support from Department of Veterans Affairs,. The institution of Dr. Nirenberg has received research support from National Institutes of Health. The institution of Dr. Nirenberg has received research support from American Parkinson Disease Association. An immediate family member of Dr. Nirenberg has received publishing royalties from a publication relating to health care. Dr. Nirenberg has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with Parkinson's Foundation. Dr. Nirenberg has a non-compensated relationship as a Editorial board with Neurology Today that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Iris Katharina Penner, PhD The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Catherine H. Wuthrich, MD No disclosure on file
Helen Tremlett, PhD, BPharm Dr. Tremlett has nothing to disclose.
Umit H. Ulas, MD No disclosure on file
Mary Widmeyer, MD No disclosure on file
Konrad P. Weber, MD Dr. Weber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weber has received intellectual property interests from a discovery or technology relating to health care. Dr. Weber has a non-compensated relationship as a Medical Advisor with MachineMD that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
David B. Watson, MD, FÂ鶹´«Ã½Ó³»­ Dr. Watson has nothing to disclose.
Timothy E. Lotze, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Brigitte Stemper, MD No disclosure on file
Alan C. Tse, MD No disclosure on file
Bryan K. Woodruff, MD The institution of Dr. Woodruff has received research support from National Institute on Aging.
Leonard Verhagen Metman, MD, PhD Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Jose Matias No disclosure on file
Camilo Toro, MD, FÂ鶹´«Ã½Ó³»­ Dr. Toro has received personal compensation in the range of $100,000-$499,999 for serving as a TORO with NIH/IRP.
Shin Takano, MD No disclosure on file
George Thomas No disclosure on file
William J. Triggs, MD No disclosure on file
Kolawole W. Wahab, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wahab has nothing to disclose.
Spozhmy Panezai, MD Dr. Panezai has nothing to disclose.
Mya C. Schiess, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schiess has nothing to disclose.
Fabrizio Stocchi Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
Lilia Mesa, MD No disclosure on file
Alessandro Serra, MD Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Hiangkiat Tan No disclosure on file
Sharief Taraman, MD Dr. Taraman has received personal compensation for serving as an employee of Cognoa. Dr. Taraman has received personal compensation for serving as an employee of Pediatric Subspecialty Faculty. Dr. Taraman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cognito Therapeutics . Dr. Taraman has stock in Handzin. Dr. Taraman has stock in Cognoa. The institution of Dr. Taraman has received research support from Innovative Health Solutions. Dr. Taraman has received intellectual property interests from a discovery or technology relating to health care. Dr. Taraman has received intellectual property interests from a discovery or technology relating to health care. Dr. Taraman has received intellectual property interests from a discovery or technology relating to health care.
Sirinan Tazen, MD No disclosure on file
David R. Curfman, MD Dr. Curfman has nothing to disclose.
Novraj Dhanjal, MD No disclosure on file
Pamela Foulds, MD No disclosure on file
Jason S. Hawley, MD Dr. Hawley has nothing to disclose.
Ann B. Ragin, PhD No disclosure on file
Stefan Schwab, MD Dr. Schwab has nothing to disclose.
Shumaila Sultan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sultan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Corey Goldsmith, MD, FÂ鶹´«Ã½Ó³»­ Dr. Goldsmith has received publishing royalties from a publication relating to health care.
Ken Ikeda, MD, PhD No disclosure on file
Takashi Matsukawa, MD No disclosure on file
Hana Prikrylova Vranova No disclosure on file
Patrick Pullicino, MD No disclosure on file
Eric Roy, PhD No disclosure on file
Sheila G. Srinivasan, MBBS No disclosure on file
Anthony T. Yachnis, MD No disclosure on file
Sarah Wahlster, MD Dr. Wahlster has nothing to disclose.
Bruno Stankoff, MD, PhD The institution of Bruno Stankoff, MD, PhD has received research support from Roche, Sanofi, Serono . The institution of Bruno Stankoff, MD, PhD has received research support from Novartis.
Paisith Piriyawat, MD Dr. Piriyawat has nothing to disclose.
Kathryn J. Swoboda, MD Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Swoboda has received research support from Biogen.
Okan Dogu, MD No disclosure on file
Max J. Hilz, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Ming-Jen Lee, MD, PhD No disclosure on file
Tanya Simuni, MD, FÂ鶹´«Ã½Ó³»­ Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Paola Tortorella No disclosure on file
Erdem Tuzun Erdem Tuzun has nothing to disclose.
Cindy Zadikoff, MD Dr. Zadikoff has received personal compensation for serving as an employee of AbbVie.
Teresa Coelho, MD Dr. Coelho has nothing to disclose.
Cordelia Erickson-Davis No disclosure on file
Sung-Tsang Hsieh, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Abdullahi Ibrahim, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Sheng-Han Kuo, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kuo has nothing to disclose.
Claudio Mariani, MD No disclosure on file
David G. Munoz, MD No disclosure on file
Espartaco M. Ribeiro No disclosure on file
Seymour Solomon, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
William R. Tyor, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH.
Vanessa Troiani No disclosure on file
Aleksandar Videnovic, MD, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Videnovic has nothing to disclose.
Paul Nisbet, PhD No disclosure on file
Aarti Sarwal, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Sheinkei. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Neuroimaging . The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Sarwal has a non-compensated relationship as a Secretary with American Society of Neuroimaging that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Sarwal has a non-compensated relationship as a Member, Board of Directors with Neurocritical Care Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Sarwal has a non-compensated relationship as a Section Chair, Neurosciences Section with Society of Critical Care Medicine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Suroto Setijorumekso, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Gioacchino Tedeschi, MD Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Widjojo Sutedjo, MD No disclosure on file
David B. Rye, MD, PhD No disclosure on file
David Staskin, MD No disclosure on file
Marc Verin Mr. Verin has nothing to disclose.
Bruce R. Reed, PhD No disclosure on file
Pinky H. Agarwal, MD, FÂ鶹´«Ã½Ó³»­ Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharmaceuticals. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AskBio. An immediate family member of Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in Curis Inc. An immediate family member of Dr. Agarwal has stock in Citius Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Fortress Biotech. An immediate family member of Dr. Agarwal has stock in TG Therapeutics. An immediate family member of Dr. Agarwal has stock in ATYR PHARMA INC . An immediate family member of Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . An immediate family member of Dr. Agarwal has stock in LAVA THERAPEUTICS . An immediate family member of Dr. Agarwal has stock in OVID THERAPEUTICS INC . An immediate family member of Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. An immediate family member of Dr. Agarwal has stock in ProQr Therapeutics. An immediate family member of Dr. Agarwal has stock in Mind Medicine. An immediate family member of Dr. Agarwal has stock in Lyra Therapeutics. An immediate family member of Dr. Agarwal has stock in Larimer Therapeutics. An immediate family member of Dr. Agarwal has stock in Lantern Pharma. An immediate family member of Dr. Agarwal has stock in Black Diamond Therapeutics. An immediate family member of Dr. Agarwal has stock in Amylyx Pharma. An immediate family member of Dr. Agarwal has stock in Palisade Bio. An immediate family member of Dr. Agarwal has stock in Inozyme Pharma. An immediate family member of Dr. Agarwal has stock in Pyxis Oncology. An immediate family member of Dr. Agarwal has stock in Vertex Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Vyne Therapeutics. An immediate family member of Dr. Agarwal has stock in Reviva Pharmaceuticals Hld. An immediate family member of Dr. Agarwal has stock in Immuneering Corp. An immediate family member of Dr. Agarwal has stock in Imunon Inc. An immediate family member of Dr. Agarwal has stock in Enlivex Therapeutics. An immediate family member of Dr. Agarwal has stock in Candel Therapeutics. An immediate family member of Dr. Agarwal has stock in Applied Digital Corp. An immediate family member of Dr. Agarwal has stock in Atai Life Sciences. An immediate family member of Dr. Agarwal has stock in Adma Biologics. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus. The institution of Dr. Agarwal has received research support from Nova Nordisc. The institution of Dr. Agarwal has received research support from Inhibikase. The institution of Dr. Agarwal has received research support from Intracellular therapeurtics.
Iftekhar Ahmed, MD, PC, FÂ鶹´«Ã½Ó³»­ Dr. Ahmed has nothing to disclose.
Daniel Capruso, PhD No disclosure on file
Marc Dinkin, MD Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bush Graziano Rice & Platter, P.A.. Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Luks, Santiello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Luks and Santaniello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, PC.
Kwang-Ki Kim, MD No disclosure on file
Bennett L. Lavenstein, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Raija Lindberg, MD No disclosure on file
Eric N. Miller, PhD No disclosure on file
Jeffrey Rumbaugh, MD No disclosure on file
Ray L. Watts, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Christopher Gomez, MD, PhD Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.
Marlis Gonzalez-Fernandez, MD, PhD No disclosure on file
Hee Young Hwang No disclosure on file
Matthias Mehling, MD The institution of Dr. Mehling has received research support from Swiss National Science Foundation. The institution of Dr. Mehling has received research support from Roche. The institution of Dr. Mehling has received research support from Merck.
Sandra R. Richman, MD No disclosure on file
Jacqueline M. Winterkorn, MD PhD No disclosure on file
Joshua A. Sonnen No disclosure on file
Dietrich A. Stephan, PhD Dr. Stephan has received personal compensation for serving as an employee of NeuBase Therapeutics, Inc.. Dr. Stephan has received stock or an ownership interest from Peptilogics, Inc.. Dr. Stephan has received stock or an ownership interest from Sharp Edge Labs, Inc.. Dr. Stephan has received stock or an ownership interest from Pendulum Therapeutics, Inc.. Dr. Stephan has received stock or an ownership interest from FarmaceuticalRx.
Helio Afonso G. Teive, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Teive has nothing to disclose.
Victor Valcour, MD Dr. Valcour has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IAS-USA. Dr. Valcour has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
Sarah Tomaszewski-Farias No disclosure on file
Martin A. Nogues No disclosure on file
Ola A. Selnes, PhD No disclosure on file
Robert C. Sergott, MD Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Liana Rosenthal, MD Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Pharmaceuticals. Dr. Rosenthal has received research support from NIH. Dr. Rosenthal has received research support from Gordon and Marilyn Macklin Foundation. Dr. Rosenthal has received research support from The Daniel B. and Florence E. Green Foundation. Dr. Rosenthal has received research support from National Ataxia Foundation. Dr. Rosenthal has received research support from Michael J. Fox Foundation. Dr. Rosenthal has received research support from Pfizer. Dr. Rosenthal has received research support from Biohaven Pharmaceuticals. Dr. Rosenthal has a non-compensated relationship as a Medical Director, ex-officio Member of the Board with National Ataxia Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
John N. Soltys, MD Dr. Soltys has nothing to disclose.
Bing-Wen Soong, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Ching Piao Tsai, MD No disclosure on file
Ron Neumann, MD No disclosure on file
Kristen A. Smith, MD No disclosure on file
Thomas L. Winder, PhD, FACMG Dr. Winder has nothing to disclose.
Richard L. Skolasky, BA No disclosure on file
Len Walt, MD No disclosure on file
Annette Wundes, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Jun Xu, MD No disclosure on file
Lauren C. Flynn, DO No disclosure on file
Hoe Chin Chua, MD No disclosure on file
Brianna Morgan No disclosure on file
Fernando L. Pagan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Janakan Ravindran, MBBS No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Stefan Bittner Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Biogen Idec. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Merck Healthcare. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Novartis. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Roche. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Sanofi. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Bristol-Meyer-Squibbs. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Teva.
Rachel Goldmann Gross, MD No disclosure on file
Hasti Poya No disclosure on file
Susan Roberson, RN No disclosure on file
Jennifer Schymick No disclosure on file
Aaron Vinik No disclosure on file
Cornelia Reininger No disclosure on file
Ned C. Sacktor, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Andres M. Villa, MD Dr. Villa has nothing to disclose.
Francesca Rosini, MD No disclosure on file
Fabrizio Salvi, MD No disclosure on file
Iuliana Slesari No disclosure on file
Paul Sauleau, MD No disclosure on file
Bryan M. Spann, DO, PhD No disclosure on file
Matthew J. Thurtell, MD Dr. Thurtell has received publishing royalties from a publication relating to health care.
Margaret Park, MD No disclosure on file
Krzysztof Bujarski, MD Dr. Bujarski has nothing to disclose.
John M. Hourihane, MD No disclosure on file
Barry M. Czeisler, MD, MS, MHPE, FÂ鶹´«Ã½Ó³»­ Dr. Czeisler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroStat Consulting LLC. Dr. Czeisler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroStat Consulting LLC. Dr. Czeisler has stock in Brainspace. Dr. Czeisler has received publishing royalties from a publication relating to health care.
Seth A. Smith, PhD Dr. Smith has nothing to disclose.
Alireza Noorian, MD No disclosure on file
William Hayward, MD, PhD No disclosure on file
Nyaz Didehbani, PhD Dr. Didehbani has nothing to disclose.
Raghav Govindarajan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Bahram Mokri, MD No disclosure on file
Anna E. Blanken Ms. Blanken has nothing to disclose.
Galyna Pushchinska, MD No disclosure on file
Florencia Aguirre No disclosure on file
Viviane H. Zetola, MD Dr. Zetola has nothing to disclose.
Imad R. Khan, MD The institution of Dr. Khan has received research support from National Institute of Neurological Diseases and Stroke. The institution of Dr. Khan has received research support from National Heart Lung and Blood Institute. The institution of Dr. Khan has received research support from National Institute of Neurological Diseases and Stroke.
Masa-Aki Higuchi, MD No disclosure on file
Kushak Suchdev, MD Dr. Suchdev has nothing to disclose.
Anteneh M. Feyissa, MD, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis.
Miguel J. Lainez, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Holger Kaube, MD No disclosure on file
Richard D. Dortch, PhD Dr. Dortch has nothing to disclose.
Preet M. Varade, MD Dr. Varade has nothing to disclose.
Richard T. Benson, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Benson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Journals (Â鶹´«Ã½Ó³»­). Dr. Benson has received personal compensation in the range of $100,000-$499,999 for serving as a Federal employee with HHS/NIH.
Elizabeth Diebolt No disclosure on file
Klaus-Georg E. Werner, MD No disclosure on file
Tonette Gehrking Tonette Gehrking has nothing to disclose.
Umair Saeed, MD No disclosure on file
Priyank Patel, MD Dr. Patel has nothing to disclose.
Syed I. Hussain, MD Dr. Hussain has nothing to disclose.
Venkatachalam Mangeshkumar, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Madaline B. Harrison, MD Dr. Harrison has nothing to disclose.
Neha Safi, MD No disclosure on file
Esha Khurana No disclosure on file
Olanrewaju Agbe-Davies, MD, MBBS No disclosure on file
Wondwossen G. Tekle, MD Dr. Tekle has nothing to disclose.
Allyson Zazulia An immediate family member of Dr. Zazulia has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care Society.
Steven S. Schreiber, MD Dr. Schreiber has nothing to disclose.
James Baier No disclosure on file
Umer Akbar, MD Dr. Akbar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LANGaware.
Matthew Senjem Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Reuben Burshtein, MD No disclosure on file
Carlos Otavio Brandao, MD, PhD No disclosure on file
David Baker No disclosure on file
Adam D. Wallace, MD Dr. Wallace has nothing to disclose.
GAMZE BALCI CAMSARI, MD No disclosure on file
Nathan Tagg, MD Dr. Tagg has stock in Apple, Birkshire Hathaway, Medtronic.
Padraig E. O'Suilleabhain, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. O'Suilleabhain has received research support from ONO pharmaceutical. The institution of Dr. O'Suilleabhain has received research support from Integrated Research Laboratories.
Asaff Harel, MD Dr. Harel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute.
Rafael P. Dias-Carneiro, MD No disclosure on file
Kelly Wong No disclosure on file
John K. Lynch, DO, MPH Dr. Lynch has nothing to disclose.
Hillary A. Williams, MD No disclosure on file
Mia Ko, DO No disclosure on file
Karla P. Figueroa Ms. Figueroa has nothing to disclose.
Mark Anderson, MD No disclosure on file
Keith R. Albrektson No disclosure on file
Christian M. Cabrera Kang, MD No disclosure on file
Kwan Ng, MD, PhD Dr. Ng has nothing to disclose.
Max R. Mandelbaum, MD, PhD No disclosure on file
Ross Zafonte, DO Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MYOMO. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kisbee. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. The institution of Dr. Zafonte has received research support from NIDILRR. The institution of Dr. Zafonte has received research support from NIH. The institution of Dr. Zafonte has received research support from FPHS study. Dr. Zafonte has received publishing royalties from a publication relating to health care.
Quynh Pham, MD No disclosure on file
Rachel Marie E. Salas, MD, MEd, FÂ鶹´«Ã½Ó³»­ Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PRIME. Dr. Salas has received publishing royalties from a publication relating to health care.
Robert N. Sawyer, Jr., MD Dr. Sawyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sawyer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Leven Gouldin and Thompson.
Dana H. Gabuzda, MD Dr. Gabuzda has nothing to disclose.
Erika S. Horta, MD Dr. Horta has nothing to disclose.
Brandon Seminatore, MD No disclosure on file
Cynthia C. Bamford, MD No disclosure on file
Anjail Sharrief, MD The institution of Dr. Sharrief has received research support from NIH. The institution of Dr. Sharrief has received research support from University of Houston . Dr. Sharrief has a non-compensated relationship as a Consultant with Abbott that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Amrou Sarraj, MD Dr. Sarraj has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker Neurovascular. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker Neurovascular. The institution of Dr. Sarraj has received research support from Stryker Neurovascular.
Joseph S. Chung, DO No disclosure on file
Edward J. Gettings, DO Dr. Gettings has nothing to disclose.
Derek Clark, MD No disclosure on file
Khaled Moussawi, MD, PhD No disclosure on file
Benjamin Emanuel, DO Dr. Emanuel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Reback McAndrews Blessey.
Jessica H. Goldstein, MD, FÂ鶹´«Ã½Ó³»­ Dr. Goldstein has nothing to disclose.
Andra L. Dingman, MD Dr. Dingman has nothing to disclose.
Guy T. Helman No disclosure on file
Alfredo H. Laffue, MD Dr. Laffue has nothing to disclose.
Patrizia Ferrero No disclosure on file
Margarita M. Aulet-Leon No disclosure on file
Ryan Crooks, MD Dr. Crooks has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Chubb.
Shyam S. Rao, MD No disclosure on file
Sarah Pirio Richardson, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pirio Richardson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Pirio Richardson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. The institution of Dr. Pirio Richardson has received research support from NIH. The institution of Dr. Pirio Richardson has received research support from DOD. The institution of Dr. Pirio Richardson has received research support from Scion. The institution of Dr. Pirio Richardson has received research support from Jazz Pharmaceuticals. The institution of Dr. Pirio Richardson has received research support from UCB. The institution of Dr. Pirio Richardson has received research support from Buk-wang Pharmaceuticals.
Tomoya Kubota No disclosure on file
Lauren C. Frey, MD No disclosure on file
Jussara M. Khouri, MD Dr. Khouri has nothing to disclose.
David C. McCarthy, Jr., MD Dr. McCarthy has nothing to disclose.
Quang D. Vu, MD No disclosure on file
Ayse Altintas, MD Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Deva. The institution of Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Vladimiro Sinay, MD No disclosure on file
Athanasios Evangeliou No disclosure on file
Harina K. Chahal, MD No disclosure on file
Siddhart K. Mehta, MD Dr. Mehta has nothing to disclose.
Julia E. Staisch, MD Dr. Staisch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Staisch has received research support from Michael J Fox.
Paula C. Azevedo, MD Dr. Azevedo has nothing to disclose.
Alicia E. Bennett, DO Dr. Bennett has nothing to disclose.
Devry M. Saenz, MD No disclosure on file
Alejandra Gonzalez No disclosure on file
Barry D. Jordan, MD Dr. Jordan has nothing to disclose.
Tyler E. Gaston, MD Dr. Gaston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Gaston has received research support from NINDS.
David M. Auerbach, MD No disclosure on file
Jaskiran Brar, MD No disclosure on file
William Panenka, MD Dr. Panenka has nothing to disclose.
Gary Hunter, MD No disclosure on file
Michal Szulc No disclosure on file
Jessica L. Winslow, MD No disclosure on file
Michael J. Lyerly, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lyerly has nothing to disclose.
Shibani S. Mukerji, MD, PhD Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.
Patrizia Casaccia, MD, PhD No disclosure on file
Husnu Efendi, MD The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alexion. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Roche. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Novartis.
Ilana L. Kahn, MD Dr. Kahn has nothing to disclose.
Sanskriti Mishra, MD No disclosure on file
Timothy Shepherd No disclosure on file
Mary Jane Lim-Fat, MD, FRCPC Dr. Lim Fat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Lim Fat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Lim Fat has received research support from Brain Cancer Canada.
Janice Wong, MD Dr. Wong has received personal compensation for serving as an employee of Janssen Research & Development. Dr. Wong has received personal compensation for serving as an employee of Biogen. Dr. Wong has stock in Biogen. Dr. Wong has stock in Janssen Research & Development.
Pooja Sofat, MBBS Dr. Sofat has nothing to disclose.
Peyman Shirani, MD No disclosure on file
Grant Iverson, PhD Grant Iverson, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sway Medical. Grant Iverson, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NanoDX. The institution of Grant Iverson, PhD has received research support from Wounded Warrior Project. Grant Iverson, PhD has received publishing royalties from a publication relating to health care. Grant Iverson, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with NeuroHealth, LLC.
Alissa A. Chitlangia, MD Dr. Chitlangia has nothing to disclose.
Emanuele D'Amico Emanuele D'Amico has nothing to disclose.
Qian Ma, MD, PhD No disclosure on file
Angelo Quartarone, MD No disclosure on file
Nicholas A. Frost, MD, PhD The institution of Dr. Frost has received research support from Simons Foundation. The institution of Dr. Frost has received research support from National Institutes of Health.
Christopher Schwarz The institution of Christopher Schwarz has received research support from NIH.
Murat Kurtuncu, MD Dr. Kurtuncu has nothing to disclose.
Amir A. Sepehry No disclosure on file
Karen Hirsch, MD The institution of Dr. Hirsch has received research support from National Institutes of Health.
Paula Barreras, MD Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from Â鶹´«Ã½Ó³»­.
Mohammed Elkider, MBBS No disclosure on file
Yiting Yang, MD No disclosure on file
Leslie A. Benson, MD The institution of Dr. Benson has received research support from ROHHAD Fight, Inc. The institution of Dr. Benson has received research support from NIH. The institution of Dr. Benson has received research support from Roche/Genentech. Dr. Benson has received personal compensation in the range of $0-$499 for serving as a consultant with MA Department of public health. Dr. Benson has received personal compensation in the range of $10,000-$49,999 for serving as a consultant with National vaccine injury compensation program.
Ayaz M. Khawaja, MD Dr. Khawaja has nothing to disclose.
Kevin N. Ramdas, MD No disclosure on file
Francisco J. Varela, MD Dr. Varela has nothing to disclose.
Kanika Arora, MD No disclosure on file
Goran Rakocevic, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rakocevic has nothing to disclose.
Amir Adeli, MD Dr. Adeli has nothing to disclose.
Erin Furr-Stimming, MD, FÂ鶹´«Ã½Ó³»­ Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from HDSA. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with Â鶹´«Ã½Ó³»­ UES Committee that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Harshil Shah, Jr., MBBS No disclosure on file
Bardia Nourbakhsh, MD Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. The institution of Dr. Nourbakhsh has received research support from Genentech. The institution of Dr. Nourbakhsh has received research support from National MS Society . The institution of Dr. Nourbakhsh has received research support from Department of Defense. The institution of Dr. Nourbakhsh has received research support from NIH. The institution of Dr. Nourbakhsh has received research support from Axsome Therapeutics. The institution of Dr. Nourbakhsh has received research support from TG Therapeutics .
Edoardo G. Spinelli, MD Dr. Spinelli has nothing to disclose.
Rik Ganguly No disclosure on file
Daniela M. Khouri, Jr., MD Dr. Khouri has nothing to disclose.
Murat Gonen No disclosure on file
Adam M. Willis, MD The institution of Dr. Willis has received research support from Air Force. Dr. Willis has received intellectual property interests from a discovery or technology relating to health care.
Margaret Esiri Margaret Esiri has stock in Cytox Group.
Maria Cristina Arci Santos No disclosure on file
Sarah J. Banks, PhD No disclosure on file
Andrew Russman, DO, FÂ鶹´«Ã½Ó³»­ Dr. Russman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific Corporation. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Mena Samaan, MD No disclosure on file
Aysegul Gunduz No disclosure on file
Matthew N. Jaffa, DO Dr. Jaffa has nothing to disclose.
Frank A. Imarhiagbe, MD No disclosure on file
Fariha Khalid, MD No disclosure on file
Jose Antonio O. Pantangco No disclosure on file
Lionel D. Vazquez-Figueroa, MD Dr. Vazquez-Figueroa has nothing to disclose.
Jared Cook No disclosure on file
Catherine Tegeler Ms. Tegeler has nothing to disclose.
Ravi Garg, MD Dr. Garg has nothing to disclose.
Andre Y. Son No disclosure on file
Jingya Zhang, PhD No disclosure on file
Tuncay Gunduz, MD The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
Sara K. Rostanski, MD Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Individual law firms.
Maureen A. Mealy, PhD, RN No disclosure on file
Jennifer P. Rubin, MD Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Passage Bio.
Sergio Lindembaum No disclosure on file
Ersida Buraniqi, MD No disclosure on file
Danah Marafie, MD Dr. Marafie has received research support from United States National Institute of Health.
Harald Pruss Harald Pruss has nothing to disclose.
Daniel Korya, MD No disclosure on file
Sandra D. Cassard, ScD No disclosure on file
Achint A. Patel No disclosure on file
Alexandra B. Kornbluh, MD Dr. Kornbluh has nothing to disclose.
Bhaskar Roy, MD, FÂ鶹´«Ã½Ó³»­ Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Roy has or had stock in Cabaletta bio. .Dr. Roy has or had stock in Pfizer.Dr. Roy has or had stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Sabrina Kuespert, PhD No disclosure on file
Vijayaleskhmi Nair, MD No disclosure on file
Thor D. Stein, MD, PhD Dr. Stein has nothing to disclose.
Virendra R. Mishra, PhD The institution of Prof. Mishra has received research support from Keep Memory Alive Young Scholar Award. The institution of Prof. Mishra has received research support from NINDS/NIA: R01NS117547-01. The institution of Prof. Mishra has received research support from NIGMS: P20GM109025.